Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	dynein complex binding	TPR CENPF KATNA1 CFAP100 RAB29	3.26e-07	28	105	5	GO:0070840
GeneOntologyMolecularFunction	glucuronosyltransferase activity	UGT2B7 UGT2B10 UGT2B28 UGT2B11	3.33e-05	35	105	4	GO:0015020
GeneOntologyMolecularFunction	cytoskeletal protein binding	TPR MAP7D3 MAP4 CENPF PARVB KATNA1 LMOD2 OPHN1 KIF3A TLN1 VPS41 KIF14 MARK2 MYO15A RAB29 PHACTR1	1.95e-04	1099	105	16	GO:0008092
GeneOntologyBiologicalProcess	biphenyl catabolic process	UGT2B7 UGT2B10 UGT2B28 UGT2B11	4.37e-08	8	105	4	GO:0070980
GeneOntologyBiologicalProcess	biphenyl metabolic process	UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.30e-07	10	105	4	GO:0018879
GeneOntologyBiologicalProcess	xenobiotic glucuronidation	UGT2B7 UGT2B10 UGT2B28 UGT2B11	3.04e-07	12	105	4	GO:0052697
GeneOntologyBiologicalProcess	establishment or maintenance of cell polarity regulating cell shape	PARVB KIF3A MARK2	5.11e-07	4	105	3	GO:0071963
GeneOntologyBiologicalProcess	cellular glucuronidation	UGT2B7 UGT2B10 UGT2B28 UGT2B11	3.55e-06	21	105	4	GO:0052695
GeneOntologyBiologicalProcess	microtubule cytoskeleton organization	TPR MAP7D3 MAP4 CUL9 PDCL2 KATNA1 KIF3A SPDL1 CFAP100 DNAI1 TUBB4A GTF2B AKAP9 KIF14 MARK2	3.63e-06	720	105	15	GO:0000226
GeneOntologyBiologicalProcess	microtubule-based process	TPR IFT140 MAP7D3 MAP4 CUL9 STARD7 PDCL2 KATNA1 KIF3A SPDL1 CFAP100 DNAI1 TUBB4A GTF2B AKAP9 KIF14 MARK2 PLTP	6.07e-06	1058	105	18	GO:0007017
GeneOntologyBiologicalProcess	establishment or maintenance of cell polarity	ATN1 MAP4 PARVB OPHN1 KIF3A SPDL1 DLG3 LRRC7 MARK2	6.68e-06	257	105	9	GO:0007163
GeneOntologyBiologicalProcess	glucuronate metabolic process	UGT2B7 UGT2B10 UGT2B28 UGT2B11	8.70e-06	26	105	4	GO:0019585
GeneOntologyBiologicalProcess	uronic acid metabolic process	UGT2B7 UGT2B10 UGT2B28 UGT2B11	8.70e-06	26	105	4	GO:0006063
GeneOntologyBiologicalProcess	benzene-containing compound metabolic process	UGT2B7 UGT2B10 UGT2B28 UGT2B11	3.68e-05	37	105	4	GO:0042537
GeneOntologyBiologicalProcess	xenobiotic catabolic process	UGT2B7 UGT2B10 UGT2B28 UGT2B11	3.68e-05	37	105	4	GO:0042178
GeneOntologyBiologicalProcess	androgen metabolic process	UGT2B7 UGT2B10 UGT2B28 UGT2B11	4.10e-05	38	105	4	GO:0008209
GeneOntologyBiologicalProcess	organelle localization	RB1 MAP4 CENPF KIF3A SPDL1 MDN1 STXBP1 AKAP9 KCNB1 SEC16A KIF14 MARK2 PDCD10	5.86e-05	703	105	13	GO:0051640
GeneOntologyBiologicalProcess	regulation of mitotic nuclear division	TOM1L2 TPR RB1 CENPF CUL9 SPDL1	6.39e-05	134	105	6	GO:0007088
GeneOntologyBiologicalProcess	dendritic cell homeostasis	FLT3 GPR183	7.68e-05	3	105	2	GO:0036145
GeneOntologyBiologicalProcess	cerebellar cortex morphogenesis	OPHN1 GLI2 KIF14 HERC1	1.04e-04	48	105	4	GO:0021696
GeneOntologyBiologicalProcess	regulation of mitotic metaphase/anaphase transition	TPR RB1 CENPF SPDL1 PHF10	1.25e-04	95	105	5	GO:0030071
GeneOntologyBiologicalProcess	regulation of organelle organization	TOM1L2 TPR IFT140 RB1 MAP4 CENPF CUL9 LMOD2 SPDL1 TUBB4A STXBP1 LMAN1 AKAP9 SEC16A MARK2 PDCD10 PHF10 CNOT1	1.39e-04	1342	105	18	GO:0033043
GeneOntologyBiologicalProcess	estrogen metabolic process	UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.42e-04	52	105	4	GO:0008210
GeneOntologyBiologicalProcess	regulation of metaphase/anaphase transition of cell cycle	TPR RB1 CENPF SPDL1 PHF10	1.45e-04	98	105	5	GO:1902099
GeneOntologyBiologicalProcess	metaphase/anaphase transition of mitotic cell cycle	TPR RB1 CENPF SPDL1 PHF10	1.59e-04	100	105	5	GO:0007091
GeneOntologyBiologicalProcess	endoplasmic reticulum to Golgi vesicle-mediated transport	CTAGE9 LMAN1 CTAGE8 SEC16A CTAGE4 RAB29	1.64e-04	159	105	6	GO:0006888
GeneOntologyBiologicalProcess	metaphase/anaphase transition of cell cycle	TPR RB1 CENPF SPDL1 PHF10	1.83e-04	103	105	5	GO:0044784
GeneOntologyBiologicalProcess	mitotic cell cycle	TOM1L2 CUL2 TPR TTC28 RB1 MAP4 CENPF CUL9 PIAS1 SPDL1 USP8 TUBB4A MASTL KIF14 PHF10	1.88e-04	1014	105	15	GO:0000278
GeneOntologyBiologicalProcess	establishment or maintenance of epithelial cell apical/basal polarity	OPHN1 DLG3 LRRC7 MARK2	2.18e-04	58	105	4	GO:0045197
GeneOntologyBiologicalProcess	cerebellum morphogenesis	OPHN1 GLI2 KIF14 HERC1	2.48e-04	60	105	4	GO:0021587
GeneOntologyBiologicalProcess	regulation of nuclear division	TOM1L2 TPR RB1 CENPF CUL9 SPDL1	2.51e-04	172	105	6	GO:0051783
GeneOntologyBiologicalProcess	regulation of sister chromatid segregation	TPR RB1 CENPF SPDL1 PHF10	2.60e-04	111	105	5	GO:0033045
GeneOntologyBiologicalProcess	smoothened signaling pathway	IFT140 RB1 EVC KIF3A PTPDC1 GLI2	2.84e-04	176	105	6	GO:0007224
GeneOntologyBiologicalProcess	establishment or maintenance of bipolar cell polarity	OPHN1 DLG3 LRRC7 MARK2	3.00e-04	63	105	4	GO:0061245
GeneOntologyBiologicalProcess	establishment or maintenance of apical/basal cell polarity	OPHN1 DLG3 LRRC7 MARK2	3.00e-04	63	105	4	GO:0035088
GeneOntologyBiologicalProcess	negative regulation of mitotic nuclear division	TOM1L2 TPR CENPF SPDL1	3.19e-04	64	105	4	GO:0045839
GeneOntologyBiologicalProcess	regulation of mitotic sister chromatid separation	TPR RB1 CENPF SPDL1	3.19e-04	64	105	4	GO:0010965
GeneOntologyBiologicalProcess	hindbrain morphogenesis	OPHN1 GLI2 KIF14 HERC1	3.19e-04	64	105	4	GO:0021575
GeneOntologyBiologicalProcess	Golgi vesicle transport	CTAGE9 LMAN1 CTAGE8 SEC16A VPS41 CTAGE4 RAB29 CCDC93	3.43e-04	339	105	8	GO:0048193
GeneOntologyBiologicalProcess	mitotic sister chromatid separation	TPR RB1 CENPF SPDL1	3.80e-04	67	105	4	GO:0051306
GeneOntologyBiologicalProcess	mitotic cell cycle process	TOM1L2 CUL2 TPR RB1 MAP4 CENPF CUL9 PIAS1 SPDL1 USP8 MASTL KIF14 PHF10	3.97e-04	854	105	13	GO:1903047
GeneOntologyBiologicalProcess	establishment of organelle localization	RB1 MAP4 CENPF KIF3A SPDL1 MDN1 STXBP1 SEC16A KIF14 PDCD10	4.73e-04	546	105	10	GO:0051656
GeneOntologyBiologicalProcess	cerebellar cortex development	OPHN1 GLI2 KIF14 HERC1	4.74e-04	71	105	4	GO:0021695
GeneOntologyBiologicalProcess	negative regulation of nuclear division	TOM1L2 TPR CENPF SPDL1	5.27e-04	73	105	4	GO:0051784
GeneOntologyBiologicalProcess	protein-containing complex localization	IFT140 OPHN1 KIF3A MDN1 AKAP9 DLG3 LRRC7	5.54e-04	278	105	7	GO:0031503
GeneOntologyBiologicalProcess	regulation of chromosome separation	TPR RB1 CENPF SPDL1	7.11e-04	79	105	4	GO:1905818
GeneOntologyBiologicalProcess	regulation of chromosome segregation	TPR RB1 CENPF SPDL1 PHF10	7.28e-04	139	105	5	GO:0051983
GeneOntologyBiologicalProcess	cell projection assembly	IFT140 MAP4 TSGA10 PARVB PDCL2 OPHN1 KIF3A CFAP100 DNAI1 PTPDC1 RAB29	7.35e-04	685	105	11	GO:0030031
GeneOntologyBiologicalProcess	xenobiotic metabolic process	CES3 UGT2B7 UGT2B10 UGT2B28 UGT2B11	7.76e-04	141	105	5	GO:0006805
GeneOntologyBiologicalProcess	vesicle cargo loading	CTAGE9 CTAGE8 CTAGE4	8.10e-04	36	105	3	GO:0035459
GeneOntologyBiologicalProcess	regulation of mitotic cell cycle	TOM1L2 TPR TTC28 RB1 CENPF CUL9 SPDL1 MASTL KIF14 PHF10	9.03e-04	594	105	10	GO:0007346
GeneOntologyBiologicalProcess	microtubule-based movement	IFT140 MAP4 STARD7 PDCL2 KIF3A CFAP100 DNAI1 KIF14 PLTP	9.35e-04	493	105	9	GO:0007018
GeneOntologyBiologicalProcess	cellular response to xenobiotic stimulus	RB1 CES3 UGT2B7 UGT2B10 UGT2B28 UGT2B11	9.64e-04	222	105	6	GO:0071466
GeneOntologyBiologicalProcess	chromosome separation	TPR RB1 CENPF SPDL1	1.07e-03	88	105	4	GO:0051304
GeneOntologyCellularComponent	axoneme	IFT140 MAP4 CENPF KIF3A CFAP100 DNAI1 TUBB4A GLI2	9.22e-06	207	104	8	GO:0005930
GeneOntologyCellularComponent	ciliary plasm	IFT140 MAP4 CENPF KIF3A CFAP100 DNAI1 TUBB4A GLI2	9.55e-06	208	104	8	GO:0097014
GeneOntologyCellularComponent	cytoplasmic region	IFT140 MAP4 CENPF KIF3A CFAP100 DNAI1 TUBB4A STXBP1 GLI2 MARK2	1.26e-05	360	104	10	GO:0099568
GeneOntologyCellularComponent	spindle	TPR MAP7D3 TTC28 RB1 MAP4 CENPF KATNA1 KIF3A SPDL1 TUBB4A KIF14	2.29e-05	471	104	11	GO:0005819
GeneOntologyCellularComponent	nuclear periphery	TPR ATN1 CENPF PIAS1 SATB1 PHF10 VDR	2.36e-05	171	104	7	GO:0034399
GeneOntologyCellularComponent	nuclear outer membrane	UGT2B7 UGT2B10 UGT2B28 UGT2B11	4.60e-05	40	104	4	GO:0005640
GeneOntologyCellularComponent	endoplasmic reticulum exit site	CTAGE9 CTAGE8 SEC16A CTAGE4	5.59e-05	42	104	4	GO:0070971
GeneOntologyCellularComponent	microtubule associated complex	TPR MAP4 KATNA1 KIF3A DNAI1 KIF14	1.55e-04	161	104	6	GO:0005875
GeneOntologyCellularComponent	microtubule organizing center	IFT140 TTC28 LRRC45 MAP4 CENPF TSGA10 EVC KATNA1 KIF3A SPDL1 CFAP100 DNAI1 AKAP9 MASTL	1.83e-04	919	104	14	GO:0005815
GeneOntologyCellularComponent	plasma membrane bounded cell projection cytoplasm	IFT140 MAP4 CENPF KIF3A CFAP100 DNAI1 TUBB4A GLI2	1.87e-04	317	104	8	GO:0032838
GeneOntologyCellularComponent	cilium	IFT140 MAP4 CENPF TSGA10 EVC KIF3A CFAP100 DNAI1 TUBB4A SHANK2 AKAP9 GLI2 KCTD10	5.12e-04	898	104	13	GO:0005929
GeneOntologyCellularComponent	postsynapse	DOCK1 MAP4 PIAS1 OPHN1 KIF3A USP8 STXBP1 SHANK2 AKAP9 KCNB1 DLG3 LRRC7 EIF3A MARK2	5.14e-04	1018	104	14	GO:0098794
GeneOntologyCellularComponent	nuclear matrix	ATN1 CENPF SATB1 PHF10 VDR	6.78e-04	140	104	5	GO:0016363
GeneOntologyCellularComponent	glutamatergic synapse	DOCK1 PRUNE2 PIAS1 OPHN1 KIF3A USP8 STXBP1 SHANK2 AKAP9 DLG3 LRRC7 MARK2	7.50e-04	817	104	12	GO:0098978
GeneOntologyCellularComponent	axon	RIN3 MAP4 KATNA1 OPHN1 KIF3A TUBB4A STXBP1 SHANK2 KCNB1 SCN9A DLG3 LRRC7	1.58e-03	891	104	12	GO:0030424
GeneOntologyCellularComponent	ciliary tip	IFT140 KIF3A GLI2	1.76e-03	48	104	3	GO:0097542
GeneOntologyCellularComponent	kinetochore	TPR CENPF SPDL1 GTF2B PHF10	2.12e-03	181	104	5	GO:0000776
GeneOntologyCellularComponent	transcription preinitiation complex	GTF2B RPRD2	2.47e-03	15	104	2	GO:0097550
HumanPheno	Single central incisor	EVC GLI2 ANKRD11 CNOT1	3.67e-05	27	37	4	HP:0001573
HumanPheno	Solitary median maxillary central incisor	EVC GLI2 ANKRD11 CNOT1	3.67e-05	27	37	4	HP:0006315
Domain	UDPGT	UGT2B7 UGT2B10 UGT2B28 UGT2B11	4.49e-06	21	101	4	PF00201
Domain	UDPGT	UGT2B7 UGT2B10 UGT2B28 UGT2B11	4.49e-06	21	101	4	PS00375
Domain	UDP_glucos_trans	UGT2B7 UGT2B10 UGT2B28 UGT2B11	4.49e-06	21	101	4	IPR002213
Domain	MYT1	MYT1 ST18	8.66e-05	3	101	2	PF08474
Domain	Myelin_TF	MYT1 ST18	8.66e-05	3	101	2	IPR013681
Domain	GPR107-like	GPR107 TMEM87B	1.73e-04	4	101	2	IPR009637
Domain	Lung_7-TM_R	GPR107 TMEM87B	1.73e-04	4	101	2	PF06814
Domain	Znf_C2HC	MYT1 ST18	4.28e-04	6	101	2	IPR002515
Domain	zf-C2HC	MYT1 ST18	4.28e-04	6	101	2	PF01530
Domain	ZF_CCHHC	MYT1 ST18	5.97e-04	7	101	2	PS51802
Domain	Cullin_CS	CUL2 CUL9	5.97e-04	7	101	2	IPR016157
Domain	Cullin_Nedd8	CUL2 CUL9	7.94e-04	8	101	2	PF10557
Domain	Cullin_Nedd8	CUL2 CUL9	7.94e-04	8	101	2	SM00884
Domain	Cullin_neddylation_domain	CUL2 CUL9	7.94e-04	8	101	2	IPR019559
Domain	VPS9	GAPVD1 RIN3	7.94e-04	8	101	2	SM00167
Domain	Cullin_homology	CUL2 CUL9	1.02e-03	9	101	2	IPR016158
Domain	Cullin	CUL2 CUL9	1.27e-03	10	101	2	PF00888
Domain	CULLIN_2	CUL2 CUL9	1.27e-03	10	101	2	PS50069
Domain	VPS9	GAPVD1 RIN3	1.27e-03	10	101	2	PS51205
Domain	VPS9	GAPVD1 RIN3	1.27e-03	10	101	2	PF02204
Domain	VPS9	GAPVD1 RIN3	1.27e-03	10	101	2	IPR003123
Domain	Cullin_N	CUL2 CUL9	1.27e-03	10	101	2	IPR001373
Domain	CULLIN_1	CUL2 CUL9	1.27e-03	10	101	2	PS01256
Domain	IRS_PTB	DOK5 TLN1	2.53e-03	14	101	2	IPR002404
Domain	IRS	DOK5 TLN1	2.53e-03	14	101	2	PF02174
Pathway	REACTOME_PREDNISONE_ADME	UGT2B7 UGT2B10 UGT2B28 UGT2B11	7.09e-06	23	78	4	MM16639
Pathway	REACTOME_GLUCURONIDATION	UGT2B7 UGT2B10 UGT2B28 UGT2B11	8.47e-06	24	78	4	MM14599
Pathway	REACTOME_GLUCURONIDATION	UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.00e-05	25	78	4	M17787
Pathway	WP_GLUCURONIDATION	UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.00e-05	25	78	4	MM15820
Pathway	KEGG_ASCORBATE_AND_ALDARATE_METABOLISM	UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.00e-05	25	78	4	M605
Pathway	WP_GLUCURONIDATION	UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.18e-05	26	78	4	M39404
Pathway	KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS	UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.61e-05	28	78	4	M19580
Pathway	REACTOME_PARACETAMOL_ADME	UGT2B7 UGT2B10 UGT2B28 UGT2B11	6.16e-05	39	78	4	MM15695
Pathway	KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM	UGT2B7 UGT2B10 UGT2B28 UGT2B11	7.52e-05	41	78	4	M7399
Pathway	REACTOME_ASPIRIN_ADME	UGT2B7 UGT2B10 UGT2B28 UGT2B11	9.95e-05	44	78	4	M45014
Pathway	REACTOME_ASPIRIN_ADME	UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.09e-04	45	78	4	MM15694
Pathway	REACTOME_SIGNALING_BY_HEDGEHOG	IFT140 PSMB10 EVC KIF3A TUBB4A GLI2	1.09e-04	137	78	6	MM15182
Pathway	KEGG_DRUG_METABOLISM_OTHER_ENZYMES	UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.78e-04	51	78	4	M17726
Pathway	REACTOME_SIGNALING_BY_HEDGEHOG	IFT140 PSMB10 EVC KIF3A TUBB4A GLI2	1.80e-04	150	78	6	M27440
Pathway	KEGG_STARCH_AND_SUCROSE_METABOLISM	UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.92e-04	52	78	4	M14171
Pathway	KEGG_STEROID_HORMONE_BIOSYNTHESIS	UGT2B7 UGT2B10 UGT2B28 UGT2B11	2.39e-04	55	78	4	M14933
Pathway	REACTOME_HEDGEHOG_OFF_STATE	IFT140 PSMB10 KIF3A TUBB4A GLI2	2.86e-04	105	78	5	MM15206
Pathway	REACTOME_HEDGEHOG_OFF_STATE	IFT140 PSMB10 KIF3A TUBB4A GLI2	4.01e-04	113	78	5	M27471
Pathway	KEGG_RETINOL_METABOLISM	UGT2B7 UGT2B10 UGT2B28 UGT2B11	4.28e-04	64	78	4	M9488
Pathway	KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450	UGT2B7 UGT2B10 UGT2B28 UGT2B11	6.03e-04	70	78	4	M16794
Pathway	KEGG_DRUG_METABOLISM_CYTOCHROME_P450	UGT2B7 UGT2B10 UGT2B28 UGT2B11	6.71e-04	72	78	4	M9257
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	EHBP1 TPR GAPVD1 TTC28 RAPH1 CENPF LCORL ZMYM2 SPDL1 LMAN1 SATB1 SEC16A KIF14 CNOT1	4.10e-11	418	106	14	34709266
Pubmed	Weak activity of UDP-glucuronosyltransferase toward Bisphenol analogs in mouse perinatal development.	UGT2B7 UGT2B10 UGT2B28 UGT2B11	2.83e-09	7	106	4	26074487
Pubmed	Hetero-oligomer formation of mouse UDP-glucuronosyltransferase (UGT) 2b1 and 1a1 results in the gain of glucuronidation activity towards morphine, an activity which is absent in homo-oligomers of either UGT.	UGT2B7 UGT2B10 UGT2B28 UGT2B11	5.65e-09	8	106	4	32093886
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	TPR GAPVD1 MAP7D3 TTC28 RAPH1 MAP4 SPDL1 TLN1 SEC16A OSBPL11 KIF14 RPRD2 CNOT1	1.37e-08	549	106	13	38280479
Pubmed	Hypertonicity-responsive ubiquitin ligase RNF183 promotes Na, K-ATPase lysosomal degradation through ubiquitination of its β1 subunit.	TOM1L2 EHBP1 TPR LPCAT1 GAPVD1 TTC28 MAP4 LMAN1 TLN1 SEC16A OSBPL11	1.36e-07	449	106	11	31732153
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	DOCK1 EHBP1 TPR GAPVD1 MAP7D3 TTC28 MAP4 LMAN1 TLN1 SEC16A LRRC7 MARK2 CNOT1	2.59e-07	708	106	13	39231216
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	DOCK1 TPR MAP4 CENPF ZMYM2 IFI16 SEC16A MASTL OSBPL11 RPRD2 MARK2	4.20e-07	503	106	11	16964243
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	DOCK1 EHBP1 PRUNE2 MAP4 MYT1 EVC ANKMY1 CTIF PARVB PTPDC1 SHANK2 GLI2 SETBP1 VPS41 ANKRD11 RPRD2 LRRC7 CNOT1	5.67e-07	1489	106	18	28611215
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	TPR GAPVD1 MAP4 CENPF CUL9 TUBB4A URB1 MDN1 TLN1 SEC16A KIF14 CNOT1	7.66e-07	653	106	12	22586326
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	EHBP1 TPR GAPVD1 MAP7D3 RAPH1 MAP4 ZMYM2 USP8 TLN1 SEC16A MASTL OSBPL11 RPRD2 EIF3A	9.87e-07	934	106	14	33916271
Pubmed	The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch.	TPR MAP7D3 RAPH1 MAP4 CENPF SPDL1 TLN1 SEC16A	1.25e-06	256	106	8	33397691
Pubmed	Comparative proximity biotinylation implicates the small GTPase RAB18 in sterol mobilization and biosynthesis.	EHBP1 TPR GAPVD1 RAPH1 MAP4 SPDL1 LMAN1 TLN1 SEC16A OSBPL11 RAB29	1.37e-06	568	106	11	37774976
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	EHBP1 GAPVD1 MAP7D3 TTC28 RAPH1 MAP4 USP8 MDN1 AKAP9 SEC16A ANKRD11 KIF14 MARK2	2.29e-06	861	106	13	36931259
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	TPR GAPVD1 CENPF ZMYM2 URB1 KCTD10 TLN1 MASTL IFFO2 KIF14 EIF3A MARK2 PDCD10 PHF10 CNOT1	2.32e-06	1155	106	15	20360068
Pubmed	A human MAP kinase interactome.	DOCK1 TOM1L2 EHBP1 TPR IFT140 ZMYM2 PIAS1 KIF3A EIF3A EPAS1	2.49e-06	486	106	10	20936779
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	LPCAT1 MAP7D3 TTC28 ZMYM2 MUC16 LMOD2 PIAS1 USP8 MDN1 STXBP1 CNOT1	4.18e-06	638	106	11	31182584
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	TPR GAPVD1 ATN1 RAPH1 MAP4 ZMYM2 IFI16 MDN1 SEC16A OSBPL11 MARK2 PHF10	4.42e-06	774	106	12	15302935
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	TTC28 CUL9 USP8 AKAP9 TLN1 SEC16A DLG3 LRRC7 ST18	4.55e-06	407	106	9	12693553
Pubmed	BioID Performed on Golgi Enriched Fractions Identify C10orf76 as a GBF1 Binding Protein Essential for Golgi Maintenance and Secretion.	TPR GAPVD1 MAP7D3 TTC28 RAPH1 TLN1 EIF3A	4.68e-06	216	106	7	31519766
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	PRUNE2 TTC28 URB1 TLN1 SETBP1 SEC16A RPRD2	6.12e-06	225	106	7	12168954
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	TPR CENPF ZMYM2 KIF3A MDN1 SHANK2 AKAP9 KCNB1 SEC16A DLG3 LRRC7 CNOT1 PHACTR1	7.68e-06	963	106	13	28671696
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	MAP4 ZMYM2 IFI16 PIAS1 GTF2B SATB1 TLN1 SEC16A MASTL	9.14e-06	444	106	9	34795231
Pubmed	Interplay between the retinoblastoma protein and LEK1 specifies stem cells toward the cardiac lineage.	RB1 CENPF	9.20e-06	2	106	2	15861132
Pubmed	Human papillomavirus type 16 E7 oncoprotein associates with the cullin 2 ubiquitin ligase complex, which contributes to degradation of the retinoblastoma tumor suppressor.	CUL2 RB1	9.20e-06	2	106	2	17609271
Pubmed	Characterization of a novel 350-kilodalton nuclear phosphoprotein that is specifically involved in mitotic-phase progression.	RB1 CENPF	9.20e-06	2	106	2	7651420
Pubmed	A targeted RNAi screen of the breast cancer genome identifies KIF14 and TLN1 as genes that modulate docetaxel chemosensitivity in triple-negative breast cancer.	TLN1 KIF14	9.20e-06	2	106	2	23479679
Pubmed	Quantitative analysis of UGT2B28 mRNA expression by real-time RT-PCR and application to human tissue distribution study.	UGT2B28 UGT2B11	9.20e-06	2	106	2	21679149
Pubmed	CMF1-Rb interaction promotes myogenesis in avian skeletal myoblasts.	RB1 CENPF	9.20e-06	2	106	2	18425850
Pubmed	CENP-F is a protein of the nuclear matrix that assembles onto kinetochores at late G2 and is rapidly degraded after mitosis.	RB1 CENPF	9.20e-06	2	106	2	7542657
Pubmed	Large-scale concatenation cDNA sequencing.	TOM1L2 LPCAT1 MAP4 SHANK2 OSBPL11 HERC1 PHF10 PLTP EPAS1 CCDC93	9.77e-06	568	106	10	9110174
Pubmed	A "double adaptor" method for improved shotgun library construction.	TOM1L2 LPCAT1 MAP4 SHANK2 OSBPL11 HERC1 PHF10 PLTP EPAS1 CCDC93	1.07e-05	574	106	10	8619474
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	EHBP1 GAPVD1 MAP7D3 TTC28 SEC16A LRRC7 CNOT1	1.68e-05	263	106	7	34702444
Pubmed	Quantitative Proteomics Links the LRRC59 Interactome to mRNA Translation on the ER Membrane.	TPR MAP4 SPDL1 MDN1 LMAN1 TLN1 EIF3A CNOT1	2.04e-05	375	106	8	32788342
Pubmed	Proteins recruited by SH3 domains of Ruk/CIN85 adaptor identified by LC-MS/MS.	MAP7D3 RAPH1 MAP4 KATNA1 KCTD10	2.08e-05	108	106	5	19531213
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	MAP7D3 MAP4 SEC16A SCN9A KIF14 RPRD2	2.22e-05	184	106	6	32908313
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	GAPVD1 CENPF DNAI1 MDN1 SCN9A ANKRD11 MARK2 HERC1 CNOT1	2.23e-05	497	106	9	36774506
Pubmed	A protein interaction landscape of breast cancer.	TOM1L2 CUL2 TPR GAPVD1 TTC28 RB1 CUL9 MDN1 TLN1 PHF10	2.50e-05	634	106	10	34591612
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	TOM1L2 TPR GAPVD1 MAP4 GPR183 URB1 SEC16A MASTL OSBPL11 HERC1 PDCD10 CNOT1 PHACTR1	2.66e-05	1084	106	13	11544199
Pubmed	HIF1α deubiquitination by USP8 is essential for ciliogenesis in normoxia.	USP8 EPAS1	2.76e-05	3	106	2	24378640
Pubmed	cDNA cloning and expression of two new members of the human liver UDP-glucuronosyltransferase 2B subfamily.	UGT2B10 UGT2B11	2.76e-05	3	106	2	8333863
Pubmed	Vitamin D Receptor Controls Cell Stemness in Acute Myeloid Leukemia and in Normal Bone Marrow.	FLT3 VDR	2.76e-05	3	106	2	31968250
Pubmed	Mutation of the proline P81 into a serine modifies the tumour suppressor function of the von Hippel-Lindau gene in the ccRCC.	CUL2 EPAS1	2.76e-05	3	106	2	36175619
Pubmed	Suppression of KIF3A inhibits triple negative breast cancer growth and metastasis by repressing Rb-E2F signaling and epithelial-mesenchymal transition.	RB1 KIF3A	2.76e-05	3	106	2	32011034
Pubmed	CUL2 is required for the activity of hypoxia-inducible factor and vasculogenesis.	CUL2 EPAS1	2.76e-05	3	106	2	18372249
Pubmed	A RIAM/lamellipodin-talin-integrin complex forms the tip of sticky fingers that guide cell migration.	RAPH1 TLN1	2.76e-05	3	106	2	26419705
Pubmed	Calcitriol Suppresses HIF-1 and HIF-2 Transcriptional Activity by Reducing HIF-1/2α Protein Levels via a VDR-Independent Mechanism.	EPAS1 VDR	2.76e-05	3	106	2	33182300
Pubmed	The small GTPase Rab29 is a common regulator of immune synapse assembly and ciliogenesis.	KIF3A RAB29	2.76e-05	3	106	2	26021297
Pubmed	The retinoblastoma protein is an essential mediator of osteogenesis that links the p204 protein to the Cbfa1 transcription factor thereby increasing its activity.	RB1 IFI16	2.76e-05	3	106	2	17439944
Pubmed	Human transcription factor protein interaction networks.	CUL2 ATN1 RB1 ZMYM2 CUL9 PIAS1 SATB1 GLI2 DGKK SEC16A RPRD2 EIF3A HERC1 PHF10 CNOT1	2.89e-05	1429	106	15	35140242
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	TOM1L2 MAP4 OPHN1 KIF3A TUBB4A STXBP1 SHANK2 KCTD10 TLN1 SEC16A DLG3 LRRC7 EIF3A MARK2 CNOT1	2.94e-05	1431	106	15	37142655
Pubmed	RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.	TPR MAP4 ZFC3H1 URB1 EIF3A CNOT1	3.75e-05	202	106	6	24639526
Pubmed	Hypoxia inducible factor 3α plays a critical role in alveolarization and distal epithelial cell differentiation during mouse lung development.	LPCAT1 TUBB4A EPAS1	4.66e-05	23	106	3	23451260
Pubmed	NOTCH1 nuclear interactome reveals key regulators of its transcriptional activity and oncogenic function.	RB1 IFI16 KIF3A MDN1 CNOT1	4.88e-05	129	106	5	23022380
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	EHBP1 CUL2 IFT140 GAPVD1 MAP7D3 RB1 KIF3A USP8 PTPDC1 LMAN1 SEC16A MARK2 CNOT1 CCDC93	4.93e-05	1321	106	14	27173435
Pubmed	Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy.	SLC15A2 UGT2B7 UGT2B28 UGT2B11	5.08e-05	66	106	4	19898482
Pubmed	Lysophosphatidylcholine Acyltransferase 1 (LPCAT1) Specifically Interacts with Phospholipid Transfer Protein StarD10 to Facilitate Surfactant Phospholipid Trafficking in Alveolar Type II Cells.	LPCAT1 STARD7	5.50e-05	4	106	2	26048993
Pubmed	Mea6 controls VLDL transport through the coordinated regulation of COPII assembly.	CTAGE9 CTAGE8	5.50e-05	4	106	2	27311593
Pubmed	Cytogenetically cryptic ZMYM2-FLT3 and DIAPH1-PDGFRB gene fusions in myeloid neoplasms with eosinophilia.	FLT3 ZMYM2	5.50e-05	4	106	2	28751768
Pubmed	Myt/NZF family transcription factors regulate neuronal differentiation of P19 cells.	MYT1 ST18	5.50e-05	4	106	2	21540077
Pubmed	Deletion of Mea6 in Cerebellar Granule Cells Impairs Synaptic Development and Motor Performance.	CTAGE9 CTAGE8	5.50e-05	4	106	2	33718348
Pubmed	Specific expression and regulation of the new melanoma inhibitory activity-related gene MIA2 in hepatocytes.	CTAGE9 CTAGE8	5.50e-05	4	106	2	12586826
Pubmed	ZER1 Contributes to the Carcinogenic Activity of High-Risk HPV E7 Proteins.	CUL2 RB1	5.50e-05	4	106	2	36346242
Pubmed	The mouse interferon-inducible gene Ifi204 product interacts with the Tpr protein, a component of the nuclear pore complex.	TPR IFI16	5.50e-05	4	106	2	12513910
Pubmed	Vitamin D promotes vascular regeneration.	EPAS1 VDR	5.50e-05	4	106	2	25015343
Pubmed	Regulation and function of family 1 and family 2 UDP-glucuronosyltransferase genes (UGT1A, UGT2B) in human oesophagus.	UGT2B7 UGT2B10	5.50e-05	4	106	2	10024527
Pubmed	MEA6 Deficiency Impairs Cerebellar Development and Motor Performance by Tethering Protein Trafficking.	CTAGE9 CTAGE8	5.50e-05	4	106	2	31244610
Pubmed	Agonist-dependent interaction of the rat somatostatin receptor subtype 2 with cortactin-binding protein 1.	SHANK2 DLG3	5.50e-05	4	106	2	10373412
Pubmed	Phosphorylation of MAP2c and MAP4 by MARK kinases leads to the destabilization of microtubules in cells.	MAP4 MARK2	5.50e-05	4	106	2	10542369
Pubmed	Reduced cholesterol and triglycerides in mice with a mutation in Mia2, a liver protein that localizes to ER exit sites.	CTAGE9 CTAGE8	5.50e-05	4	106	2	21807889
Pubmed	LEK1 is a potential inhibitor of pocket protein-mediated cellular processes.	RB1 CENPF	5.50e-05	4	106	2	14555653
Pubmed	TNFAIP1 interacts with KCTD10 to promote the degradation of KCTD10 proteins and inhibit the transcriptional activities of NF-κB and AP-1.	RIN3 KCTD10	5.50e-05	4	106	2	22810651
Pubmed	Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS.	CUL2 LPCAT1 PARVB AKAP9 SEC16A MASTL EIF3A PDCD10	5.54e-05	432	106	8	23455922
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	EHBP1 GAPVD1 RAPH1 MAP4 USP8 SHANK2 TLN1 LRRC7 MARK2	6.01e-05	565	106	9	25468996
Pubmed	Cilia gene mutations cause atrioventricular septal defects by multiple mechanisms.	IFT140 EVC DNAI1	6.03e-05	25	106	3	27340223
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	TPR GAPVD1 MAP4 CENPF URB1 MDN1 TLN1 SEC16A KIF14 EIF3A MARK2 CNOT1	6.91e-05	1024	106	12	24711643
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	GAPVD1 TTC28 USP8 AKAP9 SEC16A KIF14 MARK2 CNOT1	6.92e-05	446	106	8	24255178
Pubmed	Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.	TPR GAPVD1 MAP4 ZMYM2 TUBB4A MDN1 TLN1	7.36e-05	332	106	7	32786267
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	GAPVD1 TTC28 SPDL1 USP8 SEC16A MASTL C1D KIF14 RPRD2 RAB29	8.41e-05	733	106	10	34672954
Pubmed	The major transcriptional transactivation domain of simian virus 40 large T antigen associates nonconcurrently with multiple components of the transcriptional preinitiation complex.	RB1 GTF2B	9.15e-05	5	106	2	8551580
Pubmed	Large scale localization of protein phosphorylation by use of electron capture dissociation mass spectrometry.	CTAGE9 CTAGE8	9.15e-05	5	106	2	19131326
Pubmed	Structure of the GOLD-domain seven-transmembrane helix protein family member TMEM87A.	GPR107 TMEM87B	9.15e-05	5	106	2	36373655
Pubmed	SUMOylation by Pias1 regulates the activity of the Hedgehog dependent Gli transcription factors.	PIAS1 GLI2	9.15e-05	5	106	2	20711444
Pubmed	cTAGE: a cutaneous T cell lymphoma associated antigen family with tumor-specific splicing.	CTAGE9 CTAGE4	9.15e-05	5	106	2	12839582
Pubmed	Specific phosphopeptide enrichment with immobilized titanium ion affinity chromatography adsorbent for phosphoproteome analysis.	CTAGE9 CTAGE8	9.15e-05	5	106	2	18630941
Pubmed	Characterization and expression pattern of the novel MIA homolog TANGO.	CTAGE9 CTAGE8	9.15e-05	5	106	2	15183315
Pubmed	Mea6/cTAGE5 cooperates with TRAPPC12 to regulate PTN secretion and white matter development.	CTAGE9 CTAGE8	9.15e-05	5	106	2	38439956
Pubmed	A tissue-specific atlas of mouse protein phosphorylation and expression.	CTAGE9 CTAGE8	9.15e-05	5	106	2	21183079
Pubmed	Interactions of SKIP/NCoA-62, TFIIB, and retinoid X receptor with vitamin D receptor helix H10 residues.	GTF2B VDR	9.15e-05	5	106	2	12529369
Pubmed	Identification of proteins interacting with the rat somatostatin receptor subtype 2.	SHANK2 DLG3	9.15e-05	5	106	2	11087996
Pubmed	Kif3a deficiency reverses the skeletal abnormalities in Pkd1 deficient mice by restoring the balance between osteogenesis and adipogenesis.	KIF3A GLI2	9.15e-05	5	106	2	21151991
Pubmed	Intraflagellar transport protein 122 antagonizes Sonic Hedgehog signaling and controls ciliary localization of pathway components.	IFT140 KIF3A GLI2	9.49e-05	29	106	3	21209331
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	TOM1L2 MAP4 STXBP1 SHANK2 KCNB1 LRRC7 MARK2	9.69e-05	347	106	7	17114649
Pubmed	Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.	TOM1L2 CUL2 CENPF URB1 MDN1 LMAN1 AKAP9 EIF3A MARK2 CCDC93	1.06e-04	754	106	10	33060197
Pubmed	Human chromosome 11 DNA sequence and analysis including novel gene identification.	FADS2B SHANK2 MARK2 TRIM44	1.08e-04	80	106	4	16554811
Pubmed	MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development.	TOM1L2 RB1 ZMYM2 KIF3A GLI2 RPRD2 CNOT1	1.18e-04	358	106	7	32460013
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	RAPH1 CENPF ZFC3H1 USP8 MDN1 STXBP1 SHANK2 DGKK CTAGE8 SCN9A CES3 DLG3 EIF3A CTAGE4	1.25e-04	1442	106	14	35575683
Pubmed	Identification of transcripts with enriched expression in the developing and adult pancreas.	MYT1 LMAN1 AKAP9 TLN1 UGT2B7 UGT2B10 UGT2B28 UGT2B11 ST18	1.27e-04	624	106	9	18554416
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	PRUNE2 CUL2 GAPVD1 MAP4 SPDL1 USP8 TUBB4A TLN1 SEC16A OSBPL11 EIF3A HERC1 PDCD10 CNOT1	1.37e-04	1455	106	14	22863883
Pubmed	Spatiotemporal expression pattern of Myt/NZF family zinc finger transcription factors during mouse nervous system development.	MYT1 ST18	1.37e-04	6	106	2	24214099
Pubmed	Retinoblastoma-binding protein 2 (Rbp2) potentiates nuclear hormone receptor-mediated transcription.	RB1 VDR	1.37e-04	6	106	2	11358960
Interaction	KDM1A interactions	EHBP1 TPR GAPVD1 TTC28 RAPH1 RB1 CENPF LCORL MYT1 ZMYM2 SPDL1 CFAP100 LMAN1 AKAP9 SATB1 SEC16A KIF14 CNOT1 EPAS1 CCDC93	6.12e-08	941	104	20	int:KDM1A
Interaction	UGT2B28 interactions	UGT2B10 UGT2B28 UGT2B11	2.64e-06	6	104	3	int:UGT2B28
Interaction	RCOR1 interactions	EHBP1 TPR TTC28 RAPH1 CENPF MYT1 ZMYM2 SPDL1 LMAN1 SATB1 SEC16A CCDC93	9.22e-06	494	104	12	int:RCOR1
Interaction	PHF21A interactions	EHBP1 TPR GAPVD1 TTC28 CENPF ZMYM2 LMAN1 SEC16A KIF14 CCDC93	1.13e-05	343	104	10	int:PHF21A
Interaction	MAGEA9 interactions	ZFC3H1 KIF3A SPDL1 STXBP1 SATB1 IFFO2 KIF14 CNOT1	1.24e-05	208	104	8	int:MAGEA9
Interaction	DYNC1H1 interactions	PRUNE2 TPR FLT3 RIN3 CUL9 ZFC3H1 KATNA1 TUBB4A KIF14 RPRD2 EIF3A	4.65e-05	491	104	11	int:DYNC1H1
Interaction	HDAC1 interactions	EHBP1 TPR GAPVD1 TTC28 RAPH1 RB1 CENPF MYT1 ZMYM2 SPDL1 LMAN1 AKAP9 SATB1 GLI2 TLN1 KIF14 EPAS1	5.00e-05	1108	104	17	int:HDAC1
Interaction	PHLPP1 interactions	TPR MAP7D3 RAPH1 MAP4 CENPF SPDL1 TLN1 SEC16A MARK2	5.71e-05	333	104	9	int:PHLPP1
Interaction	DNAJC10 interactions	CUL2 FLT3 RIN3 ZMYM2 IFI16 LMAN1 AKAP9 KIF14	6.10e-05	260	104	8	int:DNAJC10
Interaction	BRCA1 interactions	CUL2 TPR GAPVD1 FLT3 TTC28 RB1 MAP4 CENPF RWDD2B IFI16 PIAS1 MDN1 TLN1 SEC16A EIF3A HERC1 CNOT1 VDR	6.59e-05	1249	104	18	int:BRCA1
Interaction	WWTR1 interactions	GAPVD1 TTC28 RAPH1 RB1 SPDL1 TLN1 SEC16A OSBPL11 RPRD2 CNOT1	6.59e-05	422	104	10	int:WWTR1
Interaction	NUP88 interactions	CUL2 TPR CTIF IFI16 PTPDC1 KIF14	8.76e-05	140	104	6	int:NUP88
Interaction	RHOB interactions	DOCK1 EHBP1 CUL2 LPCAT1 RAPH1 PIAS1 MDN1 LMAN1 KCTD10 OSBPL11 KIF14 DLG3 MARK2 HERC1	1.05e-04	840	104	14	int:RHOB
Interaction	MED4 interactions	MAP7D3 TTC28 KIF3A GTF2B TLN1 KIF14 RPRD2 CNOT1 EPAS1 VDR	1.12e-04	450	104	10	int:MED4
Interaction	SIRT7 interactions	TPR GAPVD1 RB1 MAP4 CENPF CUL9 TUBB4A URB1 MDN1 TLN1 SEC16A KIF14 CNOT1	1.18e-04	744	104	13	int:SIRT7
Interaction	GJD3 interactions	TOM1L2 EHBP1 LPCAT1 GPR107 USP8 LMAN1 SEC16A OSBPL11 MARK2 RAB29	1.20e-04	454	104	10	int:GJD3
Cytoband	4q13.2	UGT2B10 UGT2B28 UGT2B11	5.13e-05	31	106	3	4q13.2
Cytoband	Ensembl 112 genes in cytogenetic band chr4q13	UGT2B7 UGT2B10 UGT2B28 UGT2B11	4.99e-04	157	106	4	chr4q13
GeneFamily	UDP glucuronosyltransferases	UGT2B7 UGT2B10 UGT2B28 UGT2B11	8.07e-06	32	73	4	363
GeneFamily	CTAGE family	CTAGE9 CTAGE8 CTAGE4	2.77e-05	15	73	3	907
GeneFamily	Zinc fingers C2H2C-type	MYT1 ST18	4.81e-05	3	73	2	1261
GeneFamily	Cullins	CUL2 CUL9	4.43e-04	8	73	2	1032
GeneFamily	VPS9 domain containing	GAPVD1 RIN3	7.09e-04	10	73	2	928
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	DOCK1 EHBP1 CUL2 DOK5 GAPVD1 TTC28 RB1 CENPF ZMYM2 CTIF MDN1 AKAP9 KIF14 EIF3A TRIM44 CCDC93	3.45e-07	856	106	16	M4500
Coexpression	ZHONG_PFC_C3_MICROGLIA	DOK5 MAP4 CTIF KIF3A TUBB4A STXBP1 SHANK2 KCNB1 DLG3 LRRC7 TRIM44	4.72e-06	488	106	11	M39104
Coexpression	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP	MUC16 UGT2B7 UGT2B10 C1D UGT2B28 UGT2B11 ST18 VDR	1.33e-05	267	106	8	MM984
Coexpression	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN	TTC28 MAP4 MYT1 CTIF GPR107 SATB1 TMEM87B ST18 PLTP	1.71e-05	363	106	9	M6315
Coexpression	GSE1432_1H_VS_24H_IFNG_MICROGLIA_UP	ZMYM2 CTIF GPR183 SATB1 PHF10 EPAS1 VDR	1.75e-05	200	106	7	M3413
Coexpression	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN	TTC28 MAP4 MYT1 CTIF GPR107 SATB1 TMEM87B ST18 PLTP	2.08e-05	372	106	9	MM1043
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	LPCAT1 GAPVD1 CENPF ZFC3H1 AKAP9 SATB1 KIF14 CCDC93	3.06e-05	300	106	8	M8702
Coexpression	LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM	PRUNE2 ZFC3H1 OPHN1 USP8 MDN1 SHANK2 ANKRD11 MARK2 VDR	5.05e-05	417	106	9	M39224
Coexpression	VANLOO_SP3_TARGETS_DN	EVC UGT2B7 UGT2B10 UGT2B28 UGT2B11	6.29e-05	103	106	5	MM919
Coexpression	WENG_POR_TARGETS_LIVER_UP	UGT2B7 UGT2B10 UGT2B28 UGT2B11	6.35e-05	53	106	4	MM1203
Coexpression	SASAKI_ADULT_T_CELL_LEUKEMIA	DOK5 CENPF IFI16 KIF14 DLG3 PDCD10	6.37e-05	168	106	6	M15171
Coexpression	MITSIADES_RESPONSE_TO_APLIDIN_DN	TPR LPCAT1 CENPF MDN1 KIF14 EIF3A CNOT1	7.21e-05	250	106	7	M11318
Coexpression	GSE40274_CTRL_VS_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	RAPH1 RB1 MASTL KIF14 CMKLR1 EPAS1	8.24e-05	176	106	6	M9137
Coexpression	LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS	TTC28 RAPH1 AKAP9 ANKRD11 HERC1 EPAS1	8.50e-05	177	106	6	M39245
Coexpression	GSE7348_LPS_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_UP	ZMYM2 OPHN1 URB1 ANKRD11 EIF3A VDR	9.61e-05	181	106	6	M6849
Coexpression	NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP	FLT3 MAP7D3 ZMYM2 PARVB RWDD2B GPR183 GPR107 MDN1 SLC15A2 SCN9A VPS41 CMKLR1 PDCD10 CNOT1 CCDC93	1.11e-04	1215	106	15	M41122
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	EHBP1 GAPVD1 RB1 CENPF ZMYM2 MDN1 AKAP9 KIF14 CCDC93	1.18e-04	466	106	9	M13522
Coexpression	BOCHKIS_FOXA2_TARGETS	CTAGE9 PSMB10 CTAGE8 UGT2B7 UGT2B10 UGT2B28 UGT2B11 PHF10 VDR	1.19e-04	467	106	9	MM1233
Coexpression	MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN	GAPVD1 MAP7D3 ZMYM2 USP8 GTF2B SEC16A EIF3A	1.22e-04	272	106	7	M15123
Coexpression	TABULA_MURIS_SENIS_GONADAL_ADIPOSE_TISSUE_ENDOTHELIAL_CELL_AGEING	TPR CTAGE9 RIN3 TTC28 PSMB10 PIAS1 GTF2B AKAP9 TMEM87B CTAGE8 IFFO2 C1D PDCD10 PLTP	1.25e-04	1088	106	14	MM3699
Coexpression	GSE12366_GC_VS_NAIVE_BCELL_DN	RIN3 GPR183 IFI16 ANKRD11 IFFO2 TRIM44	1.44e-04	195	106	6	M3170
Coexpression	GSE15767_MED_VS_SCS_MAC_LN_DN	IFT140 ATN1 MAP4 MDN1 IFFO2 DLG3	1.61e-04	199	106	6	M3585
Coexpression	GSE23321_CD8_STEM_CELL_MEMORY_VS_EFFECTOR_MEMORY_CD8_TCELL_DN	MAP4 GPR183 MDN1 SATB1 PLTP VDR	1.61e-04	199	106	6	M8430
Coexpression	GSE3982_DC_VS_TH2_DN	TPR MAP7D3 CENPF MDN1 ANKRD11 DLG3	1.61e-04	199	106	6	M5486
Coexpression	GSE1432_1H_VS_6H_IFNG_MICROGLIA_UP	LPCAT1 ZMYM2 RWDD2B SATB1 VDR PHACTR1	1.66e-04	200	106	6	M3409
Coexpression	GSE40273_GATA1_KO_VS_WT_TREG_DN	IFT140 LPCAT1 GPR183 VPS41 ANKRD11 CCDC93	1.66e-04	200	106	6	M9133
Coexpression	TBK1.DF_DN	KIF3A SPDL1 AKAP9 TLN1 ANKRD11 C1D KIF14	1.66e-04	286	106	7	M2864
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HOMTN	DOK5 RAPH1 MAP4 MYT1 KIF3A STXBP1 SCN9A ST18	1.86e-04	389	106	8	M39073
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TTC28 STXBP1 AKAP9 SATB1 KCNB1 SEC16A ANKRD11 HERC1 ST18 VDR PHACTR1	1.48e-12	195	106	11	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TTC28 AKAP9 SATB1 KCNB1 SEC16A ANKRD11 HERC1 ST18 VDR PHACTR1	4.12e-11	195	106	10	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma\|TCGA-Brain / Sample_Type by Project: Shred V9	TOM1L2 CTIF KIF3A MDN1 SATB1 KCNB1 HERC1	2.27e-07	177	106	7	e8ab340b20cd41554c3841fe980e078e878af35f
ToppCell	PND10\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GAPVD1 MAP4 AKAP9 TLN1 ANKRD11 EIF3A EPAS1	3.67e-07	190	106	7	d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCell	Neuronal\|World / cells hierarchy compared to all cells using T-Statistic	STXBP1 SHANK2 KCNB1 SETBP1 LRRC7 HERC1 PHACTR1	5.19e-07	200	106	7	48d801219bc771d6c7e151dc88ca4c179988de85
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TPR ZFC3H1 IFI16 AKAP9 ANKRD11 EIF3A TRIM44	5.19e-07	200	106	7	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	10x5'-bone_marrow-Myeloid_Dendritic-DC2\|bone_marrow / Manually curated celltypes from each tissue	DOCK1 FLT3 GPR183 ST18 VDR PHACTR1	3.56e-06	172	106	6	64928cea7e5b60e4bc4af016454b0173ebcc07c7
ToppCell	facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRUNE2 TTC28 SATB1 KCNB1 SEC16A PHACTR1	5.93e-06	188	106	6	a91443aa8fa8fa87f7501c59219daa0305bd0bbf
ToppCell	3'_v3-bone_marrow-Myeloid_Dendritic-Cycling_Dendritic\|bone_marrow / Manually curated celltypes from each tissue	FLT3 CENPF SCN9A KIF14 ST18 PHACTR1	6.49e-06	191	106	6	aa9c0b1b90cdb7a95d4e6332819f82cae0a79ff9
ToppCell	H1299-infected\|H1299 / Cell line, Condition and Strain	CENPF SPDL1 MDN1 AKAP9 ANKRD11 EIF3A	6.69e-06	192	106	6	9cf8049bdc3e0f81ce69042beac72b08d8f38b4e
ToppCell	VE-pDC-\|VE / Condition, Cell_class and T cell subcluster	FLT3 SETBP1 SCN9A CMKLR1 CCDC183 PHACTR1	6.89e-06	193	106	6	583724de588fcde3aeda056138c522dc0225a387
ToppCell	VE-pDC\|VE / Condition, Cell_class and T cell subcluster	FLT3 SETBP1 SCN9A CMKLR1 CCDC183 PHACTR1	6.89e-06	193	106	6	bb759dc9ef0ec41d655002f59021d62d62d44289
ToppCell	10x5'-Liver-Myeloid_Dendritic\|Liver / Manually curated celltypes from each tissue	FLT3 GPR183 SCN9A ST18 VDR PHACTR1	7.09e-06	194	106	6	e6391bc7073831847c469ef0b0c437118e1f151f
ToppCell	distal-Hematologic-Myeloid_Dendritic_Type_2-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	FLT3 RIN3 GPR183 SATB1 ST18 VDR	7.30e-06	195	106	6	7606b8b40e704bb5447ac57ccf8698794e9c7890
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	STXBP1 SHANK2 KCNB1 SETBP1 LRRC7 PHACTR1	7.52e-06	196	106	6	676c56b44ac29f7baecb62f49bb8597cc74c0a88
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TSGA10 CFAP100 SHANK2 AKAP9 KCNB1 MDH1B	7.74e-06	197	106	6	74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9
ToppCell	Somatosensory_Cortex_(S1)-Neuronal\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	STXBP1 SHANK2 KCNB1 SETBP1 LRRC7 PHACTR1	7.97e-06	198	106	6	c01091ef18e096d792ea2a7a715764a5b215355f
ToppCell	primary_auditory_cortex_(A1C)-Neuronal\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	STXBP1 SHANK2 KCNB1 SETBP1 LRRC7 PHACTR1	7.97e-06	198	106	6	6d18b45eda4014759e6dd282d78ffd28df8a6044
ToppCell	severe-pDC\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	FLT3 GPR183 SETBP1 SCN9A CCDC183 PHACTR1	7.97e-06	198	106	6	3c4820a8391088682fb3e47b914f872533bae227
ToppCell	Tracheal-10x5prime-Immune_Myeloid-Dendritic_cell-DC_2\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	FLT3 RIN3 GPR183 PDCL2 ST18 PHACTR1	7.97e-06	198	106	6	25b40926412a15ca91f30cd57a547a60396e9dd3
ToppCell	Parenchymal-10x3prime_v2-Immune_Myeloid-Dendritic_cell-DC_2\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	FLT3 RIN3 GPR183 ST18 VDR PHACTR1	7.97e-06	198	106	6	115f564af8d7b89ac0331d3831faaef694043fd4
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	KIF3A STXBP1 SHANK2 SETBP1 LRRC7 HERC1	7.97e-06	198	106	6	0ff30edfd3c133a42e8cb96e1631a1143215f808
ToppCell	Parenchymal-10x3prime_v2-Immune_Myeloid-Dendritic_cell\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	FLT3 RIN3 GPR183 ST18 VDR PHACTR1	8.20e-06	199	106	6	d330e28075096a09da3c27db8b52e364967c1e34
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW23-Neuronal-Cortical_neuron\|GW23 / Sample Type, Dataset, Time_group, and Cell type.	TTC28 MAP4 TUBB4A STXBP1 SHANK2 LRRC7	8.44e-06	200	106	6	7bba2ff09349c8db3d1ccf53520b12cbf7b0abac
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuronal-Cortical_neuron\|GW26 / Sample Type, Dataset, Time_group, and Cell type.	MAP4 TUBB4A STXBP1 SHANK2 AKAP9 SCN9A	8.44e-06	200	106	6	5b3df61ff421846ef4cabf1bd5355534c8b95509
ToppCell	facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYT1 SCN9A LRRC7 MYO15A ST18	2.53e-05	145	106	5	96712c68ab759d7ade0d912581a1a7c25dc6def8
ToppCell	Control-Epithelial_airway-Ciliated_cells-Ciliated\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANKMY1 PDCL2 CFAP100 DNAI1 MDH1B	3.38e-05	154	106	5	4e3bc24043144143842627cacf6f90dda2228910
ToppCell	Control-Epithelial_airway-Ciliated_cells\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANKMY1 PDCL2 CFAP100 DNAI1 MDH1B	3.38e-05	154	106	5	7556a4b2b062da5ae7ec2bbb66e745e7662db628
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-DC-cDC2-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	FLT3 GPR183 MROH7 VDR PHACTR1	3.59e-05	156	106	5	0f54d62c0fc08bbdd5ac743b2d5d748c3d1e6ef9
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Radial_glial-gliogenic/outer_RGCs_and_astrocytes\|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.	DOCK1 RIN3 IFI16 IFFO2 MYO15A	3.70e-05	157	106	5	2c1219ee19a6246a3b9f5c2c1a37f26ea934a822
ToppCell	tumor_Lymph_Node_/_Brain-Myeloid_cells-pDCs\|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass	FLT3 GPR183 SETBP1 SCN9A CMKLR1	3.82e-05	158	106	5	2af7beb48272e5368d9ba6b80f08d47ab8556c08
ToppCell	severe_influenza-cDC\|World / disease group, cell group and cell class (v2)	DOCK1 FLT3 OPHN1 SCN9A CES3	4.17e-05	161	106	5	802f8cafb5f499e3b2ec0193d6eb1ac9320b9287
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma\|TCGA-Brain / Sample_Type by Project: Shred V9	TOM1L2 CTIF OPHN1 MDN1 KCNB1	4.17e-05	161	106	5	347edb0de10850b7d16c40945751033289289c9b
ToppCell	368C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	RB1 IFI16 SCN9A CMKLR1 PLTP	4.43e-05	163	106	5	4b8abbad4df040c895e3afb240759ebbc66b4d0e
ToppCell	PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_G2M\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CENPF SPDL1 SATB1 MASTL KIF14	4.83e-05	166	106	5	a41a20cef053c67da2d435e3e132ce28f1661c03
ToppCell	3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CTAGE9 MUC16 SLC15A2 SETBP1 MYO15A	5.11e-05	168	106	5	de0b00bc405c898d08a06b2e585fb62c0ab9a66e
ToppCell	tumor_Lymph_Node_/_Brain-B_lymphocytes-Plasma_cells\|B_lymphocytes / Location, Cell class and cell subclass	DOK5 IFT140 MUC16 LMAN1 EPAS1	5.26e-05	169	106	5	150c08c7b1dc0f46173a7b8f6a3fc70d82906c0d
ToppCell	10x5'-blood-Myeloid_Dendritic\|blood / Manually curated celltypes from each tissue	FLT3 GPR183 SCN9A ST18 PHACTR1	6.20e-05	175	106	5	1c48eec300d5a6d4a810947b995af3b8c0a5a601
ToppCell	COPD-Myeloid-pDC\|COPD / Disease state, Lineage and Cell class	FLT3 PARVB GPR183 SETBP1 SCN9A	6.55e-05	177	106	5	415aa023195a7f961c09529f65cdcc7bb90eaf5d
ToppCell	Healthy/Control-pDC\|Healthy/Control / Disease group and Cell class	DOCK1 FLT3 SCN9A CCDC183 PHACTR1	6.72e-05	178	106	5	072b346c6bbd63f00efaceda486400a669b3ec48
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYT1 PDCL2 HERC1 ST18 PHACTR1	6.72e-05	178	106	5	fcbbcc44271515de1969b4732b6441c012693d5f
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic-plasmacytoid_dendritic_cell\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	FLT3 SETBP1 SCN9A CMKLR1 CCDC183	6.90e-05	179	106	5	124da6f882968dc0d05f3edd8f3b4d61617cc214
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	FLT3 SETBP1 SCN9A CMKLR1 CCDC183	6.90e-05	179	106	5	edc5ef693dc4e7ea70717b77fb908fc784dce3a2
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	LPCAT1 MYT1 EVC UGT2B7 VDR	6.90e-05	179	106	5	55bc69f107fc710db7617c428575792adfdbbcc1
ToppCell	moderate-Myeloid-pDC\|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	GPR183 MDN1 SETBP1 SCN9A CCDC183	7.09e-05	180	106	5	1d8df7df03a71f49d6683554d3c948ce90dda42e
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	LPCAT1 MYT1 EVC UGT2B7 VDR	7.66e-05	183	106	5	83592c332b1e82673f993d37c7f480befdc3dcda
ToppCell	normal_Lung-B_lymphocytes-GrB-secreting_B_cells\|normal_Lung / Location, Cell class and cell subclass	FLT3 GPR183 SCN9A ANKRD11 CCDC183	7.66e-05	183	106	5	c930b957d16f9b0904b6c424acd914532e5cc137
ToppCell	367C-Lymphocytic-NK_cells-Proliferating_NK_cell\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	CENPF CUL9 SPDL1 MASTL KIF14	7.66e-05	183	106	5	a716b446c2bf5aa294b8f580aa845098fae76354
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TPR USP8 TLN1 ANKRD11 EIF3A	7.86e-05	184	106	5	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	PND07-Epithelial-Epithelial_Airway-Neurosecretory-PNEC\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PRUNE2 DOK5 MYT1 SCN9A ST18	7.86e-05	184	106	5	3e5c68a99c10eb1ddc1048bea4aa9f6b8e2746ff
ToppCell	PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_dendritic-im_conventional_dendritic_(19)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	FLT3 GPR183 RAB29 ST18 VDR	7.86e-05	184	106	5	315bb14e848d8e8e4533122047df6f9b89b89d99
ToppCell	PND07-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PRUNE2 DOK5 MYT1 SCN9A ST18	7.86e-05	184	106	5	1e2f0cec50475a1cf2973a5082826bbc60fc9a68
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Dendritic-conventional_dendritic_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FLT3 GPR183 LMOD2 RAB29 VDR	8.06e-05	185	106	5	209c7d769dd01c349f0a6d147ac9d6225a85160f
ToppCell	BAL-Mild-Myeloid-pDC-pDC\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	FLT3 GPR183 SETBP1 SCN9A CCDC183	8.06e-05	185	106	5	f4588468e8654363f48adbe427dff10f16f1c7fe
ToppCell	Adult-Immune-interstitial_macrophage_(C1Q_positive)-D175\|Adult / Lineage, Cell type, age group and donor	RAPH1 PARVB GPR183 CMKLR1 PLTP	8.06e-05	185	106	5	ab5704b96f1d368911308797d10c7c52766ab134
ToppCell	BAL-Mild-Myeloid-pDC-pDC-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	FLT3 GPR183 SETBP1 SCN9A CCDC183	8.06e-05	185	106	5	3cb816fc9541c04b4436e21d984216cfbbacff98
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Dendritic-conventional_dendritic_cell-DC1_(conventional_dendritic_cell)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FLT3 GPR183 LMOD2 RAB29 VDR	8.06e-05	185	106	5	1f37191eeddaf95e1ad1a206fee86525a2e94e51
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Dendritic-conventional_dendritic_cell-DC1_(conventional_dendritic_cell)-DC1_L.1.2.1.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FLT3 GPR183 LMOD2 RAB29 VDR	8.06e-05	185	106	5	70d3f804b43a8843c5af53aefe677fdfc8bb61ff
ToppCell	ILEUM-inflamed-(3)_MNP-(3)_pDC\|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	GPR183 SETBP1 SCN9A ANKRD11 CCDC183	8.06e-05	185	106	5	308a98f111895071d8772bc010554471cc12fab2
ToppCell	BAL-Mild-Myeloid-pDC\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	FLT3 GPR183 SETBP1 SCN9A CCDC183	8.06e-05	185	106	5	c2e70405969616c28fb6379ee318e17bbcef7b49
ToppCell	PBMC-Severe-Myeloid-pDC-pDC-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	FLT3 GPR183 SCN9A CCDC183 PHACTR1	8.27e-05	186	106	5	31df1eafa3010bc1be6fc4d4689f1393d69b6b13
ToppCell	PBMC-Severe-Myeloid-pDC\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	FLT3 GPR183 SCN9A CCDC183 PHACTR1	8.27e-05	186	106	5	eaa431ccd4cdd36fe06a44987603ec9979025aa8
ToppCell	Mild-Lymphoid-pDC\|Mild / Condition, Lineage, Cell class and cell subclass	FLT3 GPR183 SETBP1 SCN9A CCDC183	8.27e-05	186	106	5	7fa82972c726025d6402e5eb7bf0db3b699eba4c
ToppCell	tumor_Lung-Myeloid_cells-pDCs\|Myeloid_cells / Location, Cell class and cell subclass	GPR183 SETBP1 SCN9A ANKRD11 CCDC183	8.27e-05	186	106	5	3d7c1a281fb82db4471283f39937007d889a5f38
ToppCell	343B-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	RB1 GLI2 SCN9A CMKLR1 PLTP	8.27e-05	186	106	5	9673367cb53bafb873a01ef6bda11d9f392ce648
ToppCell	PBMC-Severe-Myeloid-pDC\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	FLT3 GPR183 SCN9A CCDC183 PHACTR1	8.27e-05	186	106	5	b95be984e308d4f9061274a35995ec558d434e74
ToppCell	PBMC-Severe-Myeloid-pDC-pDC-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	FLT3 GPR183 SCN9A CCDC183 PHACTR1	8.27e-05	186	106	5	8f7949740286f64e034d1eb533ebc2c6f71ae966
ToppCell	BAL-Mild-Myeloid-pDC-pDC\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	FLT3 GPR183 SETBP1 SCN9A CCDC183	8.27e-05	186	106	5	b031f4e6867b6200b85f43276a34749bf5f4603f
ToppCell	PBMC-Severe-Myeloid-pDC-pDC\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	FLT3 GPR183 SCN9A CCDC183 PHACTR1	8.27e-05	186	106	5	95c7318e521fb6aa02e244b1e81e6b2a62107756
ToppCell	10x5'-Liver-Myeloid_Dendritic-DC2\|Liver / Manually curated celltypes from each tissue	FLT3 GPR183 ST18 VDR PHACTR1	8.27e-05	186	106	5	92ef569c8f864d3abaa087cd3ce0366e8f9f50c2
ToppCell	BAL-Mild-Myeloid-pDC\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	FLT3 GPR183 SETBP1 SCN9A CCDC183	8.27e-05	186	106	5	d2fbf53aac905c9896272ec5c2db28ee1a60f4be
ToppCell	PBMC-Severe-Myeloid-pDC-pDC\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	FLT3 GPR183 SCN9A CCDC183 PHACTR1	8.27e-05	186	106	5	b70cd94c651b56dcf2e55554533a5f1130845390
ToppCell	COVID-19_Severe-Myeloid-pDC\|COVID-19_Severe / Disease group, lineage and cell class	FLT3 GPR183 SCN9A CCDC183 PHACTR1	8.27e-05	186	106	5	3db5ed69d49e5d79f990aca0295ddce4c297a05c
ToppCell	Mild-Lymphoid-pDC-\|Mild / Condition, Lineage, Cell class and cell subclass	FLT3 GPR183 SETBP1 SCN9A CCDC183	8.27e-05	186	106	5	1d05e73ae2ec0cc27f79e4fa40d6b21790059f80
ToppCell	BAL-Mild-Myeloid-pDC-pDC-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	FLT3 GPR183 SETBP1 SCN9A CCDC183	8.27e-05	186	106	5	79aedd5aed72509a4925e9f6cb43bc0c798c86f5
ToppCell	3'_v3-blood-Myeloid_Dendritic-DC2\|blood / Manually curated celltypes from each tissue	GPR183 SCN9A ST18 VDR PHACTR1	8.48e-05	187	106	5	9f3db9f0e5de34aeabfe5984f675bc7a65435df7
ToppCell	Mild_COVID-19-Myeloid-pDC\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	FLT3 GPR183 SETBP1 SCN9A CCDC183	8.48e-05	187	106	5	99c3c4a7b9179dce7982dc6516d561c952abc80e
ToppCell	control-pDC\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	FLT3 SCN9A CMKLR1 CCDC183 PHACTR1	8.48e-05	187	106	5	c78aee98b32719aa45811b620fc97be1ecf5fd53
ToppCell	droplet-Kidney-nan-21m-Endothelial-kidney_cortex_artery_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRUNE2 PARVB KCTD10 PLTP EPAS1	8.92e-05	189	106	5	2ce330d8078833c05775c481e73770f9ee4a5c88
ToppCell	PBMC-Mild-Myeloid-cDC-cDC-cDC_5\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	FLT3 GPR183 ST18 VDR PHACTR1	8.92e-05	189	106	5	c81b38cda4525254fe4fa137a4c9bc9abe0363bb
ToppCell	droplet-Kidney-nan-21m-Endothelial-Pecam____Kidney_cortex_artery_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRUNE2 PARVB KCTD10 PLTP EPAS1	8.92e-05	189	106	5	473c87036e04a058b4a5138438b7ba7e1e766799
ToppCell	Control-Myeloid-pDC\|Control / Disease group, lineage and cell class	FLT3 GPR183 SCN9A CCDC183 PHACTR1	8.92e-05	189	106	5	46770b99da42f11f10cfc67cea8562342d60b867
ToppCell	PBMC-Mild-Myeloid-cDC-cDC-cDC_5\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	FLT3 GPR183 ST18 VDR PHACTR1	8.92e-05	189	106	5	807922b5ea0faddd3abfa9ec1b53f3f2b00e61bf
ToppCell	PBMC-Control-Myeloid-pDC\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	FLT3 GPR183 SCN9A CCDC183 PHACTR1	9.14e-05	190	106	5	adffa93635da10251f28b2089fd96b189775c8b4
ToppCell	PBMC-Control-Myeloid-pDC-pDC\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	FLT3 GPR183 SCN9A CCDC183 PHACTR1	9.14e-05	190	106	5	9a91bf1ea105029e6412d0d9060bca325299ce26
ToppCell	PBMC-Control-Myeloid-pDC-pDC\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	FLT3 GPR183 SCN9A CCDC183 PHACTR1	9.14e-05	190	106	5	39c8ddc2639bf3e986dae11fbae61a735614b604
ToppCell	droplet-Kidney-KIDNEY-30m-Endothelial-Pecam____Kidney_cortex_artery_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRUNE2 PARVB KCTD10 PLTP EPAS1	9.14e-05	190	106	5	cb8798839c27f307955fcc94a1ee40bca95b8e99
ToppCell	PBMC-Control-Myeloid-pDC\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	FLT3 GPR183 SCN9A CCDC183 PHACTR1	9.14e-05	190	106	5	2c1c079fd411c03bc3f383aa927eea9446716960
ToppCell	356C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	RB1 IFI16 TMEM87B CMKLR1 PLTP	9.14e-05	190	106	5	d541e076137cf7334bdb0ed69db2f9a27c668c65
ToppCell	droplet-Kidney-KIDNEY-30m-Endothelial-kidney_cortex_artery_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRUNE2 PARVB KCTD10 PLTP EPAS1	9.14e-05	190	106	5	5bf3d0beee69879c95265d07fba023626a7cc808
ToppCell	PBMC-Control-Myeloid-pDC-pDC-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	FLT3 GPR183 SCN9A CCDC183 PHACTR1	9.14e-05	190	106	5	a95aea3aa707fc4574810706341a5f32b3d00209
ToppCell	PBMC-Control-Myeloid-pDC-pDC-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	FLT3 GPR183 SCN9A CCDC183 PHACTR1	9.14e-05	190	106	5	18dfa84c62dcf081ce9958a71e76a394ec0968e4
ToppCell	LV-08._Macrophage\|World / Chamber and Cluster_Paper	RIN3 SCN9A CMKLR1 ST18 PLTP	9.37e-05	191	106	5	e7a0bc46ba9ba772636a583f3387748418e18832
ToppCell	IPF-Myeloid-cDC2\|World / Disease state, Lineage and Cell class	FLT3 PARVB GPR183 ST18 VDR	9.37e-05	191	106	5	9fda87fb6bc5b8b6c0214ec909ebbc9f3f65319b
ToppCell	droplet-Lung-LUNG-1m-Endothelial-Vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TTC28 PARVB KCNB1 PLTP EPAS1	9.37e-05	191	106	5	9fc674a58f20b47255e4457d5195c8cff17b0414
ToppCell	LPS_only-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PARVB STXBP1 SCN9A EPAS1 PHACTR1	9.37e-05	191	106	5	a7b18bcf27c38ad2353c239ecb309c80f3ef3359
ToppCell	droplet-Lung-LUNG-1m-Endothelial-vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TTC28 PARVB KCNB1 PLTP EPAS1	9.37e-05	191	106	5	c379a499dabf3c9ed80f47adbb2d949821c5b053
ToppCell	droplet-Kidney-KIDNEY-1m-Endothelial-kidney_cortex_artery_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRUNE2 PARVB KCTD10 PLTP EPAS1	9.60e-05	192	106	5	c0498baa2556e1597c00df2e75efadeb14bd34ef
ToppCell	droplet-Lung-1m-Endothelial-venous_endothelial\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TTC28 PARVB KCNB1 PLTP EPAS1	9.60e-05	192	106	5	1990dc8a81594018a5bf596be99d0b5f0af0f58f
ToppCell	RV-08._Macrophage\|World / Chamber and Cluster_Paper	RIN3 CENPF SCN9A CMKLR1 PLTP	9.60e-05	192	106	5	a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	TSGA10 TUBB4A GTF2B STXBP1 SATB1 KCNB1 GLI2 CES3 PLTP	1.58e-07	184	103	9	3643_UP
Drug	C1 11-32	UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.15e-06	18	103	4	CID000443077
Drug	C11131	UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.15e-06	18	103	4	CID000443076
Drug	T4-G	UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.45e-06	19	103	4	CID000152424
Drug	estriol-16-glucuronide	UGT2B7 UGT2B10 UGT2B28 UGT2B11	2.23e-06	21	103	4	CID000122281
Drug	Piperacillin sodium salt [59703-84-3]; Down 200; 7.4uM; PC3; HT_HG-U133A	EHBP1 TPR DOK5 ATN1 MAP4 ZMYM2 IFI16 TLN1	2.86e-06	194	103	8	4320_DN
Drug	Oxybutynin chloride [1508-65-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A	DOCK1 RB1 MAP4 PARVB SHANK2 LMAN1 SLC15A2 TLN1	2.98e-06	195	103	8	6770_DN
Drug	Piperacillin sodium salt [59703-84-3]; Up 200; 7.4uM; MCF7; HT_HG-U133A	DOK5 IFT140 CUL9 SHANK2 LMAN1 CES3 MARK2 CCDC93	3.09e-06	196	103	8	3420_UP
Drug	estradiol-3-glucuronide	UGT2B7 UGT2B10 UGT2B28 UGT2B11	3.27e-06	23	103	4	CID000066651
Drug	Thalidomide [50-35-1]; Up 200; 15.4uM; PC3; HT_HG-U133A	PRUNE2 IFT140 ANKMY1 CTIF TUBB4A URB1 KCNB1 GLI2	3.46e-06	199	103	8	2095_UP
Drug	Phenethicillin potassium salt [132-93-4]; Up 200; 10uM; HL60; HT_HG-U133A	CUL2 DOK5 ATN1 RB1 MAP4 GPR107 DLG3 PHACTR1	3.59e-06	200	103	8	2542_UP
Drug	L-idaro-1,4-lactone	UGT2B7 UGT2B10 UGT2B28 UGT2B11	7.44e-06	28	103	4	CID000078997
Drug	7-hydroxycoumarin glucuronide	UGT2B7 UGT2B10 UGT2B28 UGT2B11	8.60e-06	29	103	4	CID000125641
Drug	AC1Q6OQG	UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.46e-05	33	103	4	CID000009686
Drug	BP-3,6-quinol	UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.46e-05	33	103	4	CID000119292
Drug	lithocholic acid	GTF2B UGT2B7 UGT2B10 UGT2B28 UGT2B11 VDR	1.47e-05	116	103	6	CID000009903
Drug	AC1NOWCJ	UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.86e-05	35	103	4	CID005120112
Drug	3-[(3S,5R,10S,13R,14S,17R)-3-[(2S,4R,5R,6S)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one	UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.86e-05	35	103	4	CID010436171
Drug	estrone-3-glucuronide	UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.86e-05	35	103	4	CID000115255
Drug	2-hydroxyestriol	UGT2B7 UGT2B11	2.03e-05	2	103	2	ctd:C008012
Drug	l-borneol	UGT2B7 UGT2B10 UGT2B28 UGT2B11	2.33e-05	37	103	4	CID000010049
Drug	Flupentixol dihydrochloride cis-(Z) [2413-38-9]; Down 200; 7.8uM; HL60; HT_HG-U133A	EHBP1 TPR ZMYM2 CTIF LMAN1 AKAP9 CCDC93	2.46e-05	189	103	7	1288_DN
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HG-U133A	IFI16 GPR107 SPDL1 STXBP1 OSBPL11 HERC1 EPAS1	2.54e-05	190	103	7	1971_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HG-U133A	MAP4 IFI16 GPR107 STXBP1 SATB1 OSBPL11 EPAS1	2.54e-05	190	103	7	1400_UP
Drug	Pempidine tartrate [546-48-5]; Down 200; 13uM; MCF7; HT_HG-U133A	EHBP1 TPR ATN1 TTC28 MAP4 ZMYM2 MARK2	2.63e-05	191	103	7	3926_DN
Drug	Etifenin [63245-28-3]; Down 200; 12.4uM; HL60; HT_HG-U133A	DOK5 RIN3 MAP7D3 MAP4 ZMYM2 IFI16 PHACTR1	2.81e-05	193	103	7	2477_DN
Drug	Molindone hydrochloride [15622-65-8]; Down 200; 12.8uM; PC3; HT_HG-U133A	IFT140 ATN1 PARVB TLN1 MARK2 MYO15A EPAS1	3.00e-05	195	103	7	4199_DN
Drug	Flumethasone [2135-17-3]; Up 200; 9.8uM; PC3; HT_HG-U133A	RIN3 ATN1 RB1 MYT1 KCNB1 TLN1 VDR	3.00e-05	195	103	7	4272_UP
Drug	Triamcinolone [124-94-7]; Down 200; 10.2uM; MCF7; HT_HG-U133A	MAP4 ANKMY1 CTIF URB1 LMAN1 TLN1 VDR	3.00e-05	195	103	7	2241_DN
Drug	Cefepime hydrochloride [123171-59-5]; Down 200; 7.4uM; HL60; HT_HG-U133A	EHBP1 TPR RB1 CTIF ANKRD11 EPAS1 PHACTR1	3.00e-05	195	103	7	6159_DN
Drug	Stachydrine hydrochloride; Down 200; 22.2uM; PC3; HT_HG-U133A	RIN3 TTC28 CENPF EVC GPR107 SHANK2 VPS41	3.10e-05	196	103	7	4469_DN
Drug	harmol	UGT2B7 UGT2B10 UGT2B28 UGT2B11	3.18e-05	40	103	4	CID000068094
Drug	Idazoxan hydrochloride [79944-56-2]; Down 200; 16.6uM; PC3; HT_HG-U133A	MYT1 TUBB4A AKAP9 GLI2 TLN1 EPAS1 CCDC93	3.21e-05	197	103	7	6747_DN
Drug	Kawain [500-64-1]; Down 200; 17.4uM; MCF7; HT_HG-U133A	IFT140 ATN1 TTC28 MAP4 CTIF GPR107 TLN1	3.21e-05	197	103	7	4693_DN
Drug	Kynurenine, 3-hydroxy (R,S) [2147-61-7]; Up 200; 17.8uM; MCF7; HT_HG-U133A	PRUNE2 CTIF TUBB4A SHANK2 KCNB1 SETBP1 VPS41	3.21e-05	197	103	7	5641_UP
Drug	(cis-) Nanophine [5072-45-7]; Up 200; 26.8uM; MCF7; HT_HG-U133A	FLT3 ATN1 CENPF MYT1 ANKMY1 SATB1 KCNB1	3.31e-05	198	103	7	4363_UP
Drug	Dubinidine [22964-77-8]; Down 200; 14.6uM; MCF7; HT_HG-U133A	IFT140 MAP4 ANKMY1 AKAP9 MARK2 RAB29 CCDC93	3.31e-05	198	103	7	3554_DN
Drug	Scopolamine hydrochloride [55-16-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A	TSGA10 CUL9 GPR107 AKAP9 TLN1 RPRD2 CCDC93	3.42e-05	199	103	7	4803_DN
Drug	testosterone glucuronide	UGT2B7 UGT2B10 UGT2B28 UGT2B11	3.52e-05	41	103	4	CID000108192
Drug	2-AF	UGT2B7 UGT2B10 UGT2B28 UGT2B11	3.52e-05	41	103	4	CID000005800
Drug	5 alpha-androstane	UGT2B7 UGT2B10 UGT2B28 UGT2B11 VDR	4.00e-05	84	103	5	CID000094144
Drug	androsterone glucuronide	UGT2B7 UGT2B10 UGT2B28 UGT2B11	4.26e-05	43	103	4	CID000114833
Drug	7,8-benzoquinoline	UGT2B7 UGT2B10 UGT2B28 UGT2B11	4.26e-05	43	103	4	CID000009191
Drug	MS-222	UGT2B7 UGT2B10 UGT2B28 UGT2B11	4.67e-05	44	103	4	CID000011400
Drug	2-naphthol	PSMB10 UGT2B7 UGT2B10 UGT2B28 UGT2B11	6.51e-05	93	103	5	CID000008663
Drug	salicylamide	UGT2B7 UGT2B10 UGT2B28 UGT2B11	6.60e-05	48	103	4	CID000005147
Drug	DCNB	SCN9A UGT2B7 UGT2B10 UGT2B28 UGT2B11	7.21e-05	95	103	5	CID000007443
Drug	AC1NQGK1	UGT2B7 UGT2B10 UGT2B28 UGT2B11	9.05e-05	52	103	4	CID005195977
Drug	oxazepam	UGT2B7 UGT2B10 UGT2B28 UGT2B11	9.75e-05	53	103	4	CID000004616
Drug	THRX 165724	FLT3 RB1	1.21e-04	4	103	2	ctd:C475928
Drug	5-((5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl)-N-(2-hydroxy-3-morpholin-4-ylpropyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide	FLT3 RB1	1.21e-04	4	103	2	ctd:C513935
Drug	chrysin	ATN1 UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.21e-04	106	103	5	CID005281607
Drug	7-methoxycoumarin	UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.30e-04	57	103	4	CID000010748
Drug	phenolphthalein	UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.39e-04	58	103	4	CID000004764
Drug	urochloralic acid	UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.48e-04	59	103	4	CID003036914
Drug	4-hydroxybiphenyl	UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.48e-04	59	103	4	CID000007103
Drug	4-hydroxyestrone	UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.48e-04	59	103	4	CID000018418
Drug	acetaminophen glucuronide	UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.48e-04	59	103	4	CID000083944
Drug	SN-38G	UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.48e-04	59	103	4	CID000443154
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	TTC28 KIF3A TUBB4A GTF2B STXBP1 RAB29	1.55e-04	177	103	6	7324_UP
Drug	UDP-alpha-d-xylopyranose	UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.59e-04	60	103	4	CID000001165
Drug	trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A	TTC28 KIF3A TUBB4A GTF2B STXBP1 EPAS1	1.81e-04	182	103	6	6879_UP
Drug	3-OHBaP	UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.92e-04	63	103	4	CID000025890
Drug	fibrates	LPCAT1 UGT2B7 UGT2B10 UGT2B28 UGT2B11	2.01e-04	118	103	5	CID000002797
Drug	ZK159222	RB1 VDR	2.01e-04	5	103	2	ctd:C410228
Drug	Ciclopirox ethanolamine [41621-49-2]; Down 200; 15uM; MCF7; HT_HG-U133A	TTC28 CENPF GPR107 SPDL1 URB1 KIF14	2.09e-04	187	103	6	5023_DN
Drug	Chlorambucil [305-03-3]; Down 200; 13.2uM; PC3; HT_HG-U133A	EHBP1 TPR MAP4 CENPF LMAN1 EPAS1	2.22e-04	189	103	6	3788_DN
Drug	DNCB	SCN9A UGT2B7 UGT2B10 UGT2B28 UGT2B11 TRIM44	2.22e-04	189	103	6	CID000000006
Drug	Piracetam [7491-74-9]; Down 200; 28.2uM; MCF7; HT_HG-U133A	MAP7D3 TTC28 MAP4 ZMYM2 LMAN1 AKAP9	2.35e-04	191	103	6	2861_DN
Drug	Convolamine hydrochloride [500-56-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A	TSGA10 GPR107 SHANK2 LMAN1 VDR PHACTR1	2.35e-04	191	103	6	2771_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A	TPR MAP4 IFI16 STXBP1 SATB1 EPAS1	2.41e-04	192	103	6	1284_UP
Drug	Flunisolide [3385-03-3]; Up 200; 9.2uM; PC3; HT_HG-U133A	PRUNE2 ATN1 CTIF TUBB4A KCNB1 TLN1	2.41e-04	192	103	6	4303_UP
Drug	Resveratrol [501-36-0]; Down 200; 17.6uM; MCF7; HT_HG-U133A	TTC28 RB1 CENPF SPDL1 AKAP9 KIF14	2.41e-04	192	103	6	2865_DN
Drug	Tranylcypromine hydrochloride [1986-47-6]; Down 200; 23.6uM; HL60; HG-U133A	EHBP1 TPR ZMYM2 LMAN1 RAB29 CCDC93	2.48e-04	193	103	6	1417_DN
Drug	Azacytidine-5 [320-67-2]; Up 200; 16.4uM; MCF7; HT_HG-U133A	MAP4 MYT1 CUL9 KCNB1 CES3 PLTP	2.48e-04	193	103	6	3348_UP
Drug	Simvastatin [79902-63-9]; Up 200; 9.6uM; MCF7; HT_HG-U133A	DOK5 ATN1 TTC28 KCNB1 CES3 MARK2	2.48e-04	193	103	6	3340_UP
Drug	Seneciphylline [480-81-9]; Down 200; 12uM; MCF7; HT_HG-U133A	CUL2 ZMYM2 GPR107 SLC15A2 KIF14 RAB29	2.55e-04	194	103	6	4822_DN
Drug	Dipyrone [5907-38-0]; Up 200; 12uM; PC3; HT_HG-U133A	ATN1 CTIF KCNB1 SLC15A2 TLN1 VDR	2.55e-04	194	103	6	4310_UP
Drug	Flumethasone [2135-17-3]; Down 200; 9.8uM; PC3; HT_HG-U133A	EHBP1 TPR CENPF ZMYM2 IFI16 LMAN1	2.55e-04	194	103	6	4272_DN
Drug	Meldola	UGT2B7 UGT2B10 UGT2B28 UGT2B11	2.58e-04	68	103	4	CID000081507
Drug	Hesperidin [520-26-3]; Up 200; 6.6uM; MCF7; HT_HG-U133A	IFT140 ZMYM2 SHANK2 LMAN1 AKAP9 CCDC93	2.62e-04	195	103	6	5313_UP
Drug	Pyrvinium pamoate [3546-41-6]; Down 200; 3.4uM; PC3; HT_HG-U133A	DOCK1 LPCAT1 PARVB TUBB4A GLI2 CCDC93	2.62e-04	195	103	6	6339_DN
Drug	Propoxycaine hydrochloride [550-83-4]; Down 200; 12uM; MCF7; HT_HG-U133A	IFT140 ATN1 CUL9 GPR107 TLN1 RAB29	2.62e-04	195	103	6	3583_DN
Drug	Mephenytoin [50-12-4]; Down 200; 18.4uM; MCF7; HT_HG-U133A	DOCK1 ATN1 TTC28 ANKMY1 GPR107 LMAN1	2.62e-04	195	103	6	3580_DN
Drug	Trimethobenzamide hydrochloride [554-92-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A	DOK5 RIN3 ATN1 MAP4 MYT1 VDR	2.62e-04	195	103	6	4180_DN
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HG-U133A	RB1 STXBP1 LMAN1 SATB1 SLC15A2 EPAS1	2.62e-04	195	103	6	1732_UP
Drug	Piromidic acid [19562-30-2]; Down 200; 13.8uM; MCF7; HT_HG-U133A	ATN1 TSGA10 ZMYM2 RAB29 CCDC93 VDR	2.62e-04	195	103	6	4398_DN
Drug	Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	CUL2 MAP7D3 MAP4 PSMB10 ZMYM2 DLG3	2.70e-04	196	103	6	987_DN
Drug	Carbinoxamine maleate salt [3505-38-2]; Down 200; 9.8uM; MCF7; HT_HG-U133A	RB1 ANKMY1 SHANK2 SLC15A2 CES3 CCDC93	2.70e-04	196	103	6	6786_DN
Drug	Fluticasone propionate [80474-14-2]; Down 200; 8uM; MCF7; HT_HG-U133A	DOCK1 ATN1 TTC28 MAP4 CUL9 ANKMY1	2.70e-04	196	103	6	7348_DN
Drug	Hexamethonium dibromide dihydrate [55-97-0]; Up 200; 10uM; MCF7; HT_HG-U133A	DOCK1 CTIF GPR107 SLC15A2 CES3 MARK2	2.70e-04	196	103	6	4965_UP
Drug	Buflomedil hydrochloride [35543-24-9]; Up 200; 11.6uM; HL60; HT_HG-U133A	FLT3 MAP4 TSGA10 IFI16 URB1 AKAP9	2.70e-04	196	103	6	1338_UP
Drug	Cefamandole sodium salt [30034-03-8]; Down 200; 8.2uM; MCF7; HT_HG-U133A	TTC28 CTIF PARVB TLN1 RPRD2 VDR	2.70e-04	196	103	6	4718_DN
Drug	Trihexyphenidyl-D,L Hydrochloride [58947-95-8]; Down 200; 11.8uM; HL60; HT_HG-U133A	RB1 MAP4 URB1 SLC15A2 PLTP VDR	2.70e-04	196	103	6	2158_DN
Drug	Domperidone maleate; Down 200; 7.4uM; HL60; HT_HG-U133A	MAP7D3 MAP4 CENPF GPR107 TLN1 CCDC93	2.70e-04	196	103	6	1301_DN
Drug	staurosporine; Down 200; 0.01uM; MCF7; HG-U133A	MAP7D3 ZMYM2 GPR107 TLN1 DLG3 VDR	2.70e-04	196	103	6	425_DN
Drug	Cephalosporanic acid, 7-amino [957-68-6]; Down 200; 14.6uM; MCF7; HT_HG-U133A	DOCK1 IFT140 ATN1 MAP4 DLG3 MARK2	2.70e-04	196	103	6	4826_DN
Drug	methoxyresorufin	UGT2B7 UGT2B10 UGT2B28 UGT2B11	2.72e-04	69	103	4	CID000119220
Drug	Lisuride (S)(-) [18016-80-3]; Down 200; 11.8uM; PC3; HG-U133A	TTC28 PARVB KIF3A GPR107 ANKRD11 DLG3	2.77e-04	197	103	6	1962_DN
Drug	Chloramphenicol [56-75-7]; Down 200; 12.4uM; PC3; HT_HG-U133A	DOCK1 EHBP1 MAP4 TLN1 ANKRD11 MARK2	2.77e-04	197	103	6	1795_DN
Disease	plasma clozapine-to-N-desmethylclozapine ratio measurement	UGT2B7 UGT2B10 UGT2B11	3.22e-06	9	101	3	EFO_0600040
Disease	Polydactyly	IFT140 CENPF EVC KIF3A GLI2	5.26e-05	117	101	5	C0152427
Disease	disease progression measurement	UGT2B7 EIF3A HERC1 UGT2B11	5.81e-05	61	101	4	EFO_0008336
Disease	alcohol consumption measurement	DOCK1 TOM1L2 EHBP1 RAPH1 LCORL KATNA1 AKAP9 SETBP1 ANKRD11 RPRD2 MYO15A RAB29 ST18 PHACTR1	8.55e-05	1242	101	14	EFO_0007878
Disease	migraine without aura	C1D PHACTR1	1.15e-04	5	101	2	MONDO_0100431
Disease	Early Childhood Epilepsy, Myoclonic	STXBP1 SCN9A	3.20e-04	8	101	2	C0393695
Disease	Idiopathic Myoclonic Epilepsy	STXBP1 SCN9A	3.20e-04	8	101	2	C0338478
Disease	Symptomatic Myoclonic Epilepsy	STXBP1 SCN9A	3.20e-04	8	101	2	C0338479
Disease	Benign Infantile Myoclonic Epilepsy	STXBP1 SCN9A	3.20e-04	8	101	2	C0751120
Disease	deoxycholic acid glucuronide measurement	UGT2B7 UGT2B10	3.20e-04	8	101	2	EFO_0800575
Disease	Myoclonic Encephalopathy	STXBP1 SCN9A	3.20e-04	8	101	2	C0438414
Disease	Acute erythroleukemia - M6a subtype	FLT3 RB1	3.20e-04	8	101	2	C2930975
Disease	Acute myeloid leukemia FAB-M6	FLT3 RB1	3.20e-04	8	101	2	C2930976
Disease	Acute erythroleukemia - M6b subtype	FLT3 RB1	3.20e-04	8	101	2	C2930977
Disease	Acute erythroleukemia	FLT3 RB1	3.20e-04	8	101	2	C2930974
Disease	Myoclonic Absence Epilepsy	STXBP1 SCN9A	3.20e-04	8	101	2	C0393703
Disease	pulse pressure measurement, migraine without aura, susceptibility to, 4	C1D PHACTR1	4.11e-04	9	101	2	EFO_0005763, MONDO_0011847
Disease	Myoclonic Epilepsy	STXBP1 SCN9A	4.11e-04	9	101	2	C0014550
Disease	basal cell carcinoma	GPR183 SEC16A ANKRD11 MYO15A VDR	4.93e-04	189	101	5	EFO_0004193
Disease	Epilepsy, Myoclonic, Infantile	STXBP1 SCN9A	5.13e-04	10	101	2	C0917800
Disease	Gastrointestinal Stromal Sarcoma	RB1 KIF3A GLI2	5.66e-04	47	101	3	C3179349
Disease	Myoclonic Astatic Epilepsy	STXBP1 SCN9A	6.25e-04	11	101	2	C0393702
Disease	Gastrointestinal Stromal Tumors	RB1 KIF3A GLI2	6.79e-04	50	101	3	C0238198
Disease	Infantile Severe Myoclonic Epilepsy	STXBP1 SCN9A	8.83e-04	13	101	2	C0751122
Disease	X-19141 measurement	UGT2B7 UGT2B11	8.83e-04	13	101	2	EFO_0800799
Disease	prostate carcinoma	TOM1L2 EHBP1 IFT140 TTC28 EVC OPHN1 SPDL1 STXBP1 SETBP1 RAB29	9.67e-04	891	101	10	EFO_0001663
Disease	Malignant neoplasm of breast	EHBP1 RAPH1 RB1 CENPF CTIF AKAP9 SETBP1 MROH7 OSBPL11 LRRC7 VDR	1.13e-03	1074	101	11	C0006142
Disease	migraine without aura, susceptibility to, 4	C1D PHACTR1	1.35e-03	16	101	2	MONDO_0011847
Disease	cervical artery dissection	C1D PHACTR1	1.53e-03	17	101	2	EFO_1000059
Disease	susceptibility to chronic sinus infection measurement	CENPF TSGA10 ST18	1.66e-03	68	101	3	EFO_0008419
Disease	phosphatidylcholine 36:4 measurement	UGT2B28 UGT2B11	1.71e-03	18	101	2	EFO_0010382
Disease	cancer (implicated_via_orthology)	FLT3 RB1 PARVB DLG3 EPAS1	2.32e-03	268	101	5	DOID:162 (implicated_via_orthology)
Disease	Antimigraine preparation use measurement	C1D PHACTR1	2.33e-03	21	101	2	EFO_0009939
Disease	bone density, lean body mass	TOM1L2 RIN3	2.33e-03	21	101	2	EFO_0003923, EFO_0004995
Disease	X-24947 measurement	UGT2B7 UGT2B11	2.56e-03	22	101	2	EFO_0800910
Disease	pulse pressure measurement	RIN3 TTC28 RAPH1 LCORL MYT1 GTF2B ANKRD11 UGT2B7 C1D ST18 CNOT1 PHACTR1	2.86e-03	1392	101	12	EFO_0005763
Disease	West Syndrome	STXBP1 PHACTR1	3.05e-03	24	101	2	C0037769
Disease	migraine disorder, Headache	C1D RPRD2 PHACTR1	3.24e-03	86	101	3	HP_0002315, MONDO_0005277

Protein segments in the cluster

Peptide	Gene	Start	Entry
IMLRSNESFTMDDMS	VDR	271	P11473
DMSTERDFFMRMKCT	EPAS1	161	Q99814
TMQTLTKQDTMLKAM	KCTD10	46	Q9H3F6
SQMLEMQVELSSMKD	AKAP9	3131	Q99996
GDLMMTSFERMLSQK	ANKRD11	1576	Q6UB99
DKMDRSMPSEMESSR	CTAGE4	651	Q8IX94
DKMDRSMPSEMESSR	CTAGE8	651	P0CG41
DKMDRSMPSEMESSR	CTAGE9	651	A4FU28
EMMTELLASARDKML	CTIF	541	O43310
SRMNMTSLDAMDISC	MASTL	671	Q96GX5
MKTRQNKDSMSMRSG	ATN1	1	P54259
MAMRKLTSMESQTDD	DNAI1	261	Q9UI46
DTKQMMSSFMLSISA	WDR83OS	76	Q9Y284
SREMMQLASEVMLSS	MROH7	716	Q68CQ1
STRTRMQKQKMNDSM	RB1	906	P06400
HMSDDSSKTMMVDER	RAPH1	276	Q70E73
SRMSRAEPTATMDDM	RAPH1	1186	Q70E73
MRVLIEKMMRNSTED	RAB29	166	O14966
EKMMRNSTEDIMSLS	RAB29	171	O14966
MESVVTTSGVMESMK	GPR107	566	Q5VW38
TLMRAQEDTVAAMMN	OPHN1	531	O60890
ETSMDFTMAKESVSM	MUC16	1066	Q8WXI7
IMTESAEMMIKTQTD	MUC16	8191	Q8WXI7
LFTSIMMKATDMLDA	MUC16	9466	Q8WXI7
QMLTRDRDFENSMKM	DGKK	1031	Q5KSL6
SSMKLSMMIQEANAI	KIF14	1086	Q15058
MTMSSIVMKAESRDI	LPCAT1	146	Q8NF37
TLKIMAMNSAMDTTE	MDN1	2086	Q9NU22
VTLAKDMQPSMESDM	MAP4	286	P27816
MSSMSRSQSVPMLDD	LRRC7	991	Q96NW7
SLSKMATDMFLAVMR	MYO15A	3066	Q9UKN7
EEAIAMVMSGKMSVS	LCORL	531	Q8N3X6
MKSVMSGDQLREDRM	GAPVD1	421	Q14C86
AMVTATNSMEETLMQ	HERC1	3126	Q15751
RMSMTSILTRNMDKQ	LMOD2	341	Q6P5Q4
GAVDEMLKTMMSVSR	C1D	26	Q13901
EEMKNEAETTSMVSM	PDCD10	6	Q9BUL8
RKDMVDMMVSSIRNT	PDCL2	211	Q8N4E4
SMTMDARLSAKMALR	PLTP	366	P55058
MKNSMSETVRLVSGM	LMAN1	406	P49257
EMTSMSAELKMRAIQ	LRRC45	396	Q96CN5
LQMKMSERAASLSTM	DOK5	246	Q9P104
MLTSLAEESKFLNMM	GLI2	1571	P10070
LSAEIEKTMSEMVTM	PTPDC1	316	A2A3K4
TMLMAAKSEMADLQQ	KIF3A	551	Q9Y496
LTTTTEMMMGRFERD	PARVB	226	Q9HBI1
RMIDELNKTLAMTMQ	PHACTR1	311	Q9C0D0
MSHITMRMSTEENRD	FADS2B	381	A8MWK0
SCLDMTMELVSMIKT	PHF10	411	Q8WUB8
DSSEREALMSELKMM	FLT3	651	P36888
EALMSELKMMTQLGS	FLT3	656	P36888
LMTKMTAMANEESRL	CCDC93	256	Q567U6
VSMNMKDAFARSIEM	KCNB1	446	Q14721
DMMSSMSDQTVRVKG	DOCK1	781	Q14185
QMKEKSSTAMEMLQT	CENPF	2431	P49454
MRKNLTQDEMQRMST	EIF3A	306	Q14152
GLSMSMDSEEAMINK	CUL2	446	Q13617
CSELSDMKIMSQDAM	CCDC183	201	Q5T5S1
SQDAMMITDEVKRNM	CCDC183	211	Q5T5S1
SSFDKGTMRRMALSM	ANKMY1	506	Q9P2S6
TTMMMSITKEEDTAA	CFAP100	441	Q494V2
KIHDLREQMMNSSMS	DLG3	476	Q92796
DEDMQSLASLMSMKQ	EHBP1	166	Q8NDI1
TSSMTTELMMVIAQE	MDH1B	96	Q5I0G3
EVGSMNITDEMKRMF	IFFO2	351	Q5TF58
EDTISKMNDFMRMQI	IFI16	446	Q16666
SEDTISKMNDFMRMQ	IFI16	501	Q16666
TTSSMEPNEMMREIR	MARK2	701	Q7KZI7
SDELRAVMFPMSTMK	MAP7D3	266	Q8IWC1
RNLSKEEMHMPTTME	KATNA1	446	O75449
MTLPTEMKEAASEMA	CUL9	651	Q8IWT3
SSKARQLMMTLTERM	EVC	336	P57679
TMEQMSREDMLAIST	CES3	361	Q6UWW8
DEMMDKPTSSSVDTM	RPRD2	736	Q5VT52
MMVKDTESRTTNGMT	SLC15A2	501	Q16348
GQNMSITEEMAEKMT	IFT140	1161	Q96RY7
DQDLLMLKATSMATM	OSBPL11	251	Q9BXB4
SSTEMLQEIRTMMTQ	RIN3	636	Q8TB24
SHMDRLMTQMAQAKE	TRIM44	301	Q96DX7
DSVMRDKDMSSFMLP	PRUNE2	1221	Q8WUY3
ENSREMTETQMMIHS	GPR183	341	P32249
MDSLRSQMEERFMSA	SCN9A	1856	Q15858
MSERVQESMSSEMLA	SPDL1	151	Q96EA4
AEMTTRMVASKMELH	PSMB10	91	P40306
MADSAELKQMVMSLR	PIAS1	1	O75925
MNTGEKTTMRDLSQM	STXBP1	316	P61764
SMLQATMTKQEADDM	URB1	726	O60287
TKDMMVEMDSLSELS	SATB1	246	Q01826
TRSDTVATMMREKGM	SHANK2	936	Q9UPX8
DMMKLQTQITSMESN	ST18	946	O60284
MSSMNERTSMNERET	CMKLR1	356	Q99788
VAKTMMESSLADFMQ	CNOT1	246	A5YKK6
MDVESRTMATMGDTL	SEC16A	1716	O15027
TMSSSDRAMMNAFKE	GTF2B	106	Q00403
DRAMMNAFKEITTMA	GTF2B	111	Q00403
TETMNVVMETNKMLR	TPR	1266	P12270
MSMKEVDEQMLSVQS	TUBB4A	321	P04350
MVDDSKTVTDMLMTI	TLN1	101	Q9Y490
IVMSKLSDQMTFMER	UGT2B11	196	O75310
SRMGNSRSALKMIME	VPS41	661	P49754
TINMNLDVSDEKMAM	RWDD2B	86	P57060
QMSNMTLMKETISTV	TSGA10	161	Q9BZW7
LTMTDMMSEDEGKTE	ZMYM2	951	Q9UBW7
EEIMTRSEMAEKMFS	TMEM87B	536	Q96K49
MVEAAMKSPMRDSLE	TTC28	166	Q96AY4
VMSKLSDQMTFMERV	UGT2B10	196	P36537
EMKRLEEMSNMFQSS	STARD7	101	Q9NQZ5
VVMSKLSDQMTFMER	UGT2B28	196	Q9BY64
VVMSELTDQMTFMER	UGT2B7	196	P16662
VRGNTKVMSEMLTEM	TOM1L2	231	Q6ZVM7
TMLREAVMATSDKLM	SETBP1	541	Q9Y6X0
MMTDKNISLIIMDAR	USP8	191	P40818
VNKDRMSMDQMAVLL	ZFC3H1	1251	O60293
STVTDESEMQDMMTR	MYT1	361	Q01538